| Nat. Prod. Rep., 2002, 19(3), 332 - 356 DOI: 10.1039/b009713f | ![]() Review Article |
|
Kenneth W. Bentley
Marrview, Tillybirloch, Midmar, Aberdeenshire, UK AB51 7PS
| Contents | |
|---|---|
| 1 | -Phenylethylamines |
| 2 | Isoquinolines |
| 3 | Naphthylisoquinolines |
| 4 | Benzylisoquinolines |
| 5 | Bisbenzylisoquinolines |
| 6 | Benzopyrrocolines |
| 7 | Pavines and isopavines |
| 8 | Berberines and tetrahydroberberines |
| 9 | Protopines |
| 10 | Phthalide–isoquinolines |
| 11 | Spirobenzylisoquinolines |
| 12 | Rhoeadines |
| 13 | Benzophenanthridines |
| 14 | Emetine and related alkaloids |
| 15 | Aporphinoid alkaloids |
| 15.1 | Proaporphines |
| 15.2 | Aporphines |
| 15.3 | Oxoaporphines |
| 15.4 | Dioxoaporphines |
| 15.5 | Aristolochic acids |
| 15.6 | Aristolactams |
| 15.7 | Azafluoranthenes and related tropolones |
| 16 | Alkaloids of the morphine group |
| 17 | Phenethylisoquinolines |
| 18 | Colchicine and related alkaloids |
| 19 | Erythrina alkaloids |
| 19.1 | Erythrinanes |
| 19.2 | Homoerythrinanes |
| 19.3 | Cephalotaxine and related alkaloids |
| 20 | Other isoquinolines |
Covering: July 2000 to June 2001. Previous review: Nat. Prod. Rep., 2001, 18, 148
This review covers
-phenylethylamines and isoquinoline alkaloids that are derived from them, including further products of oxidation, condensation with formaldehyde and rearrangement, some of which do not contain an isoquinoline system, together with naphthylisoquinoline alkaloids, which have a different biogenetic origin. The occurrence of the alkaloids, with the structures of new bases, together with their reactions, syntheses and biological activities are reported. The literature from July 2000 to June 2001 is reviewed, with 495 references cited.
-Phenylethylamines
-Phenylethylamines and amides have been isolated from the following plant species, the eleven marked with asterisks being new alkaloids:
Allium tuberosum1
N-cis-feruloyldopamine (tuberosine A)* 1, N-trans-feruloyldopamine (tuberosine B)* 2 and N-trans-coumaroyltyramine* 3
Annona glabra2
N-trans-coumaroyltyramine and N-trans-feruloyltyramine
Aristolochia mollissima3
N-cis-coumaroyltyramine* 4 and N-trans-coumaroyltyramine
Balanites aegyptica4
N-cis-feruloyltyramine and N-trans-feruloyltyramine
Mollinedia marliae5
N-trans-feruloyltyramine
Paliurus ramossisimus6
paliurine A* 5a, paliurine B* 5b, paliurine C* 6, paliurine D* 7a, paliurine E* 7b and paliurine F* 8
Turbinicarpus alonsoi7
hordenine, N,O,O-trimethyldopamine and N-methyltyramine
Zanthoxylum integrifolium8
alfileramine and integramine* 10
Of the new alkaloids integramine 10 can be regarded as the product of Hofmann degradation of alfileramine and the paliurines (above) have obvious structural similarities to integerrimine 9 and waltherines A, B and C, reported in the previous review though, unlike these four compounds, they are not derived from tyrosine.
![]() | ||
![]() | ||
![]() | ||
![]() | ||
The chromium tricarbonyl complex of 1,2,3-trimethoxybenzene reacts with the anion of acetonitrile to give, after removal of the chromium tricarbonyl, the nitrile 11a, which can be reduced to mescaline 11b.9
The tartrate esters of ephedrine and pseudoephedrine have been found to be useful derivatives for the resolution of synthetic racemic mixtures of these alkaloids.10 Ephedrine has been acylated at the amino group rather than at the hydroxy group by N-acetylaminobenzenesulfonyl chloride11 and by 4-nitrobenzoyl chloride.12 Reduction of the dibenzylaminopropiophenone 12 with borane has afforded 80% excess of the erythro alcohol, hydrogenolytic cleavage of which yielded18 fluoronorephedrine 13.13 Methods of estimating ephedrine and of norephedrine in plasma have been reported.14
![]() | ||
The pharmacological properties and physiological effects of ephedrine15–18 and of pseudoephedrine19–21 have been studied.
Simple isoquinoline alkaloids have been isolated from the following plant species:
Alangium lamarckii22
salsoline
Annona purpurea23
thalifoline
Iseia luxurians24
iseluxine 14
Turbinicarpus alonsoi7
pellotine
Iseluxine, which is a new alkaloid, is the first of this group to be found with unsubstituted hydroxy groups at positions 6 and 7 and is a simple product of cyclisation of dopamine.
![]() | ||
2-Bromohomoveratric aldehyde 15 has been condensed with the amino-alcohol 16 to give the cyclic carbinolamine ether 17, reduction of which afforded the amino alcohol 18. This has been further condensed with a variety of aldehydes to give the cyclic carbinolamine ethers 19a–19e, which have been cyclised by butyllithium, followed by a Lewis acid, to give the (1R)-tetrahydroquinolines 20 in three-fold excess over their (1S) isomers. The (1R) compounds derived from 19b–19e have been further converted into (R)-carnegine 21b, (R)-O-methylarmepavine 21c, (R)-laudanosine 21d and (R)-homolaudanosine 21e and the non-chiral O-methylcorpalline 21a has been prepared in the same way.25
![]() | ||
![]() | ||
The imine 22, prepared from 2-allylveratraldehyde and 4-methoxy-1-naphthyltyramine, on treatment with methyllithium in the presence of the chiral ligand 23 forms, through a three-component complex, the (R) chiral amine 24. Hydroboration of this affords the alcohol 25, which can be cyclised to the tetrahydroisoquinoline 26a. This can be cleaved by ammonium ceriumIII nitrate and acetic anhydride to 26b, hydrolysis of which yields (R)-salsolidine 26c.26 A synthesis of (S)-salsolidine 27 in 86% enantiomeric excess has been achieved by an enantioselective protonation of the related lithium salt in the presence of the chiral amine 28.27 A simple tetrahydrooxazaphenalene lactone containing the ABC ring system of the alkaloid stephaoxocanine 29 and the related excentricine has been synthesised.28
![]() | ||
![]() | ||
Syntheses of the isomeric 4-aryltetrahydroisoquinoline alkaloids cherylline 30a and latifine 30b have been achieved by closure of the isoquinoline ring between an aryl halide and an amide enolate.29
Naphthylisoquinoline alkaloids have been isolated from the following plant species, the ten marked with asterisks being new alkaloids:
Ancistrocladus ealaensis30
ancistroealaine A* 31 and ancistroealaine B* 32
Ancistrocladus likoko31
ancistrolikokine A* 33, ancistrolikokine B* 34, ancistrolikokine C* 34 and korupensamine A
Ancistrocladus tectorius32
ancistrotectoriline A* 36, ancistrotectoriline B* 37, 6-O-methyl-4
-O-demethylancistrocladine* 38 and 6-O-methyl-4
-Odemethylhamatine* 39
Triphyophyllum peltatum33
dioncophylline D, 8-O-methyldioncophylline D, dioncophyllinol D and 8-O-methyldioncophyllinol D* 40a
![]() | ||
![]() | ||
![]() | ||
Following the assignment of the structure 40a to 8-O-methyldioncophyllinol D, it was shown that dioncophylline D and 8-O-methyldioncophylline D have similar 7,6
-coupled structures 41a and 41b respectively rather than the 7,8
-coupled structures previously assigned to these alkaloids. Similarly dioncophyllinol D has been reformulated as 40b.33
Jozipeltine A 44, a dimer of dioncopeltine A 42a not so far encountered in plants, has been prepared. Oxidation of N,O-dibenzyldioncopeltine A 42b with silver oxide gave the quinone 43, which was reduced to the diphenol and debenzylated to jozipeltine A 44. This compound shows greatly enhanced antimalarial activity compared with dioncopeltine A, its IC50 against Plasmodium falciparum being 42 ng ml–1.34 A new, nonsymmetric 6
,8-dimer, jozimine B 46 has been prepared in good yield by the nonphenolic oxidative dimerisation of ancistrocladine 45 by lead tetraacetate and boron trifluoride; the imine 47 is also produced as a minor product in this reaction. This dimer also has greatly enhanced antimalarial activity compared with its parent monomer.35 Lead tetraacetate and phenyliodineIII bis(trifluoroacetate) have been used to achieve a convenient one-step dimerisation of dioncophylline B 48 to the unnatural dimer jozimine D 49, of korupensamine A to michellamine A and of korupensamine B to michellamine C.36
![]() | ||
![]() | ||
![]() | ||
![]() | ||
The chromium carbonyl complex 50a has been combined with the naphthylboronic acid 51 to give, after removal of the chromium carbonyl, the phenylnaphthalene 52, the cyclic ketal of which was opened to give 53a, which was converted through 53b into 54a, 54b and 54c. Bischler–Napieralsky cyclisation of 54c afforded the dihydroisoquinoline 55, which was reduced to O,O-dimethylkorupensamine A, 56a and its C-1 epimer.37 A similar sequence of reactions starting from 50b gave, after removal of the isopropyl groups, korupensamine A 56b and its C-1 epimer.38 The amine 57 has been converted into a mixture of the tetrahydroisoquinolines 58 and 59 and 58 has been further converted through 60a, 60b and 60c into the 7-bromo compound 61. Coupling of this with the tributylstannylnaphthalene 62 by the Stille process afforded N-benzyl-O,O-bis(methoxymethyl)dioncophylline B 63, which was hydrolysed and debenzylated to dioncophylline B 48.39
![]() | ||
![]() | ||
![]() | ||
![]() | ||
1-Benzylisoquinoline alkaloids have been isolated from the following plant species, that marked with an asterisk being a new alkaloid:
Annona purpurea23
reticuline
Hernandia nymphaefolia40
reticuline
Isopyrum thalictroides41
reticuline
Miliusa velutina42
reticuline
Monodora junodii43
norgorchacoine* 64
Papaver triniifolium44
crykonisine
![]() | ||
The structures of polysignine 67a and methoxypolysignine 67b have been confirmed by their preparations from O-methylarmepavine 65a and laudanosine 65b by the treatment of these alkaloids with methyl chloroformate, followed by reduction of the resulting carbamates 66a and 66b catalytically and with lithium aluminium hydride.45
![]() | ||
Nitration of N-formylnorlaudanosine 68 with nitric and acetic acids has afforded the dinitro compound 69, together with the simpler compounds 74 and 75. Direct nitration at C-5 and C-2
with hydrolysis of the C-6 methoxy group to give 69 is unexceptional, but compounds 74 and 75 must be formed by scission of the isoquinoline system, presumably through the intermediate 70, which could then suffer ring opening to the iminium salt 72, hydrolysis of which would give 74 and 75. The possibility that the dinitro
compound could be 71, formed by recyclisation of the iminium salt 72ortho rather than para to the methoxy group, was eliminated by studies of NMR spectra.46
![]() | ||
![]() | ||
Reaction of the lithium salt of 3,4-dimethoxybenzyl 1-methoxy-2-naphthyl sulfoxide with 6,7-dimethoxy-3,4-dihydroquinoline N-oxide has given the hydroxamine 76, from which (±)-laudanosine 65b was prepared by reduction.47 (R)-(+)-Laudanosine 21d has been synthesised from 19d (see section 2).25 1,2-Dehydrolaudanosine hydrochloride reacts with the bromoketone 78 to give the pyrroloisoquinoline 79a, which may be converted into the aldehyde 79b, by the Vilsmeier reaction. Hydrolyis of the methanesulfonyl ester 79b yields the hemiacetal 80, mild oxidation of which affords O,O,O-trimethyllamellarin G 81. Oxidation of 80 with manganese dioxide gives only a poor yield of 81, the main product being the quinone 82.48
![]() | ||
![]() | ||
The pharmacological properties and physiological effects of papaverine49–54 and of atracurium55–57 have been studied.
Bisbenzylisoquinolione alkaloids have been isolated from the following plant species, the nine marked with asterisks being new alkaloids:
Guatteria boliviana58
(–)-antioquine* 83, guatteboline*84, pangkorimine, philogaline*85, puertogaline A* 86a, puertogaline B* 86b and sepeerine
Hernandia nymphaefolia40
thalicarpine and vateamine 2
-N-oxide
Isolona ghesquireina59
chondrofoline, (–)-curine and isochondodendrine
Isopyrum thalictroides41
isopyruthaldine* 87, isopythaldine*88 and isothalmidine* 89
Sciadotenia toxifera60
cavanine* 90
Thalictrum orientale61
fangchinoline
![]() | ||
![]() | ||
![]() | ||
![]() | ||
(–)-Antioquine is a new alkaloid, although the (+)-isomer has been encountered previously. The structures of the new alkaloids of the group have been determined on the basis of their NMR spectra and optical properties alone. The structures assigned to the alkaloids of Isopyrum thalictroides bear no obvious relationship to those of other alkaloids recently isolated from the same species. Isothalmidine 89 is the first bisbenzylisoquinoline to be reported with a head-to-tail biphenyl linkage. Isopyruthaldine 87 and isopythaldine 88 are likewise unusual in that they purportedly are tail-to-tail diners linked through a methylene group rather than directly or through oxygen as in all other cases. Presumably their biogenesis must involve condensation of two different benzylisoquinolines with formaldehyde or equivalent. Their nearest structural analogues are the head-to-tail dimers cycloatjehine and cycloatjehenine, in which the units are linked through -O-CH2-. Further study of the of the structures of these alkaloids would be welcome.
A review of the bisbenzylisoquinoline alkaloids has ben published.62 The pharmacological properties and physiological effects of (–)-antioquine,58 of cepharanthine,64,65 of chondrofoline,59 of curine,59 of isochondodendrine,59 of guatteboline,58 of N-methylberbamine,63 of philogaline,58 of puertogalines A and B,58 of tetrandrine,66–80 of tiliacorine,81 and of tubocurarine82–85 have been studied.
The 2
-bromobenzyl-3,4-dihydroisoquinolines 91a and 91b have been cyclised, by heating with potassium carbonate, to the indolo[2,1-a]dihydroisoquinolinium salts 92a and 92b, which have been reduced catalytically and N-methylated to the benzopyrrocoline alkaloids (±)-cryptaustoline 93a and (±)-cryptowoline 93b.86
![]() | ||
Bromination of papaverine 94a to 2
-bromopapaverine 94b, followed by reduction with tributyltin hydride, gave 2
-bromo-1,2-dihydropapaverine 95a, which with ethyl chloroformate gave the carbamate 95b. This was cyclised by tetraphenylpalladium in the presence of sodium formate to N-ethoxycarbonylpavine 96a, which was reduced by lithium aluminium hydride to (±)-argemonine 96b.87 In a related process the same alkaloid was synthesised from the methiodide of 94b by a radical cyclisation, followed by reduction and N-methylation.88
![]() | ||
Alkaloids of the berberine group have been isolated from the following plant species, the two marked by asterisks being new alkaloids:
Annona glabra2
dehydrocorydalmine and kikemanine
Asteropyrum cavaleriei89
berberine, berberubine and palmatine
Isopyrum thalictroides41
columbamine and palmatine
Lindera glauca90
canadine (tetrahydroberberine)
Papaver triniifolium44
cheilanthifoline, isocorypalmine, sinactine and N-methylsinactine
Polyalthia longifolia91
8-oxopolyalthiaine* 97
Rollinia leptopetala92,93
discretamine and tetrahydrojatrorrhizine
Thalictrum acutifolium94
acutiaporberine* 98
Thalictrum orientale61
berberine
Zanthoxylum taediosum95
isocorypalmine, kikemanine, scoulerine, tetrahydropalmatine and cis-N-methyltetrahydropalmatine
![]() | ||
Acutiaporberine 98 is the first reported example of a dimer of an aporphine alkaloid and a tetrahydroberberine alkaloid similar to the bisbenylisoquinolines, aporphine–benzylisoquinoline dimers and aporphine dimers.
The influence of various media on the fluorescence of berberine chloride and implications for assays of the alkaloid96 and the absorption and reduction of berberine at the mercury electrode97 have been studied.
trans-Canadine N-oxide 99, when subjected to the Polonovski–Potier reaction has been shown to give a mixture of 7,8-dehydrocanadine 100 and the isomeric 13,14-dehydro compound 101, but in the presence of potassium cyanide 8
-cyano-canadine 102a is formed. Both 8
-cyanocanadine and 7,8-dehydrocanadine on treatment with methyl iodide yield 8
-methylcanadine 102b Under similar conditions, in the absence or presence of potassium cyanide, cis-canadine N-oxide 103 gives only 7,8-dehydrocanadine 100, though on neutralisation of the reaction product small amounts of 5
-hydroxycanadine 104a
and 5
-hydroxycanadine 104b are also formed. Similar results have been obtained with the N-oxides of thalictricavine and xylopinine.98
![]() | ||
![]() | ||
The treatment of the 2
-bromobenzyltetrahydroisoquinoline 105a with n-butyllithium affords the tetrahydroberberine 107a. 8-Oxotetrahydropalmatine 106, though not isolated from the reaction products, is assumed to be an intermediate in this reaction since it independently reacts very rapidly with n-butyllithium to give 107a in high yield. Under similar conditions 105a reacts with tert-butyllithium to give only 108 and with sec-butyllithium to give the analogue of 108, together with 109. With methyllithium 105a yields 107b,
which is reduced by sodium borohydride to 110a. In a similar manner (±)-coralydine 110b has been prepared from 105b.99
![]() | ||
![]() | ||
The 3-methoxytetrahydroisoquinoline 111 reacts with O-methyleugenol 112 and boron trifluoride to give 113, which may be oxidised by osmium tetroxide to the diol 114 and then further by periodic acid to the aldehyde 115a. Reduction of this to the alcohol 115b, followed by hydrolysis and debenzylation affords the amino-alcohol 116, which is cyclised to (±)-schefferine 117 by the Mitsunobu reaction.100 2-(2
-Bromophenylethyl)isocarbostyrils 118 have been cyclised to 8-oxoberberines 119 in good yield by
tributyltin hydride.88
![]() | ||
![]() | ||
The pharmacological properties and physiological effects of berberine,101–109 of canadine,110,111 of stepholidine,110,112 of tetrahydropalmatine113–115 and of benzyltetrahydropalmatine116 have been studied.
Alkaloids of the protopine group have been isolated from the following plant species:
Glaucium corniculatum117
allocryptopine and protopine
Glaucium flavum117
allocryptopine and protopine
Zanthoxylum integrifolium8
allocryptopine and pseudoprotopine
-Narcotine has been isolated from Papaver triniifolium.44N-Substituted derivatives of nornarcotine, such as 120, have been prepared as potential adjuvants for vaccines118 and simpler analogues, such as 121, have been shown to act as modulators of the GABAA receptor.119
The physiological effects of bicuculline have been studied.120–126
![]() | ||
The new alkaloid 8-O-acetylcorysolidine 122 has been isolated, together with corysolidine and isoochotensine, from Corydalis ochotensis.127
![]() | ||
Rhoeadine, rhoeagenine, oreodine and oreogenine have been isolated from Papaver triniifolium, together with the new alkaloids O-ethylrhoeagenine 123a and O-ethyloreogenine 123b, which may be artefacts.44
![]() | ||
Benzophenanthridine alkaloids have been isolated from the following plants species, that marked with an asterisk being a new alkaloid:
Corydalis incisa128
corynoline, acetylcorynoline, 6-oxocorynoline, corynoloxine, 12-hydroxycorynoloxine* 124 and luguine
Glaucium flavum117
chlerythrine and sanguinarine
![]() | ||
The conformation of chelidonine in deuteriochloroform has been studied by NMR spectroscopy.129O-(4-[18F]-Fluorobenzoyl)chelidonine has been prepared for possible use as an antitumour agent.130
Reaction of the iododimethoxybenzoic acid 125a with the naphthylamine 126 gives the amide 127a, the methoxymethyl derivative of which 127b is cyclised in good yield by palladiumII acetate and triphenylphosphine to the benzophenanthridine 128a, together with a small amount of the alternative benzazepine 129.131,132 The lactam 128a may be hydrolysed to 128b, which is convertible through 131 into norchelerythrine 130a by previously described methods. The trifluoromethylsulfonyloxy group has been shown to be as good a leaving group as iodine in this process.131 Nornitidine 131b may be prepared in a similar manner from 125b.131,132 A similar cyclisation of 127c yields 128c, which has been converted into chelerythrine 132.133 In approaches to alternative syntheses of benzophenanthridine alkaloids the isoquinolone 133 has been cyclised by acids to the simple unsubstitued analogue of 128c.134
![]() | ||
![]() | ||
![]() | ||
The physiological effects of chelerythrine135 and of sanguinarine136,137 have been studied.
Alangiside, alangine 134, cephaeline, 2
-N-(1-deoxy-D-fructopyranosyl)-cephaeline, 10-O-demethylcephaeline, isocephaeline, neocephaeline, protoemetine, protoemetinol, psychotrine, tubulosine, 1
,2
-dehydrotubulosine, deoxytubulosine and isotubulosine have been isolated from Alangium lamarckii.22 Alangine is reported as an alkaloid for the first time. In the last review the structure 134 was incorrectly assigned to neocephaeline.
![]() | ||
15.1 Proaporphines
The proaporphine alkaloid stepharine has been isolated from Annona glabra2 and from Annona purpurea23 and the new alkaloid promucosine 135 has been isolated from Annona purpurea.23
![]() | ||
15.2 Aporphines
Aporphine alkaloids have been isolated from the following plant species, the nine marked with asterisks being new alkaloids:
Annona glabra2anonaine, N-formylanonaine, annobraine*136a, nordomesticine and nornuciferine
Annona purpurea233apoglaziovine, isocorydine, lirindine, norglaucine, norpurpureine, northalbaicaline, romucosine F* 137, romucosine G* 138 and thalicsimidine
Asteropyrum cavaleriei89magnoflorine
Fissistigma glaucescens138xylopine and N-acetylxylopine
Glaucium corniculatum117corydine, isocorydine, glaucine and thalicmidine
Glaucium flavum117corydine, isoboldine, isocorydine and glaucine
Hernandia nymphaefolia40N-(N-methylcarbamoyl)-O-methylbulbocapnine* 139, hernandaline and laurotetanine
Isopyrum thalictroides41isocorydine
Lettowianthus stellatus139lettowianthine* 136a and 11-methoxylettowianthine* 136b
Lindera glauca90boldine, norboldine, nantenine and 3-chloro-N-formylnornantenine* 140
Miliusa velutine42,140isocorydine, isocorydine-N-oxide* 141 and norcorydine
Rollinia leptopetala92anonaine and roemerine
Stephania dinklagei141corydine
Thalictrum acutifolium94acutiaporberine* 98
Thalictrum orientale61fuzitine
![]() | ||
![]() | ||
Annobraine and lettowianthine, isolated from different species, have been assigned the same structure 136a. The separation and identification of the components of a mixture of nine aporphine alkaloids by a coupled system of high pressure liquid chromatography and NMR spectroscopy has been demonstrated.142
Glaucine 142 has been demethylated by hydrobromic acid at room temperature to a mixture of lirioferine 143a, thaliporphine 144a, N-methyllaurotetanine 144b and bracteoline 143b, though better yields were obtained at elevated temperatures.143 Bischler–Napieralsky ring closure of the amide 145 has given the dihydroisoquinolinium salt 146, which was reduced to 147a, and on treatment with methyl chloroformate this yielded 147b, which was cyclised by tributyltin hydride to give (±)-cathaformine 148.144 The efficacy of various oxidising agents in the dimerisation of dehydrowilsonirine 149 to bipowine 150 and the further oxidation of this to the extended quinone bipowinone 151 have been studied.145
![]() | ||
![]() | ||
![]() | ||
The pharmacological properties and physiological effects of boldine,146–149 of dicentrine,150 of nantenine and of apomorphine151–169 have been studied. Two glucuronides of apomorphine have been prepared170 and several (R)-aporphines related to apomorphine have been prepared by ring expansion of the ketone 152 in the quest for activity at serotonin 5-HT1A and 5-HT7 and dopamine D2A receptors.171
![]() | ||
15.3 Oxoaporphines
Oxoaporphine alkaloids have been isolated from the following plant species, the three marked with asterisks being new alkaloids:
Annona glabra2liriodenine and lysicamine
Annona purpurea23liriodenine, lysicamine, oxoglaucine and oxopurpureine
Fissistigma glaucescens138atherospermidine, fissiceine* 153, liriodenine, kuafumine, oxocrebanine and oxoglaucine
Glaucium flavum117corunnine
Guatteria boliviana58lanuginosine
Hernandia nymphaefolia40oxohernangine
Lindera glauca90lysicamine
Miliusa velutina42liriodenine
Stephania dinklagei141dicentrinone, liriodenine, N-methyliriodendronine 154a and N,2-O-dimethylliriodendronine 154b
![]() | ||
15.4 Dioxoaporphines
Dioxoaporphine alkaloids have been isolated from the following plant species:
Aristolochia mollissima3cepharadione A and 4,5-dioxodehydroasimilobine
Fissistigma balansae172noraristolodine and norcepharadione B
Fissistigma glaucescens18noraristolodione and norcepharadione B
Fissistigma oldhamii171noraristolodione and norcepharadione B
15.5 Aristolochic acids
Aristolochic acids and their esters have been isolated from the following plant species, that marked with an asterisk being a new acid:
Aristolochia curcurbitifolia1737-hydroxyaristolochic acid* 155 and aristolochic acid III methyl ester
Aristolochia kaempferi174aristolochic acid Ia methyl ester
Aristolochia mollissima3aristolochic acids I, II and IVa, aristoloterpenates I and III and aristophyllide A
![]() | ||
15.6 Aristolactams
Aristolactams have been isolated from the following plant species, the three marked with asterisks being new alkaloids:
Aristolochia curcurbitifolia173cepharanone C* 156
Aristolochiia kaempferi174aristoliukine C
Aristolochia mollissima3aristolactam N-
-D-glucoside, aristolactams AII and AIIIa, aristolactam C N-
-D-glucoside* 157 and aristoliukines A and B
aristolactams AII, AIIIa, BII, BIII, and FII, enterocarpam I, goniothalactam, piperolactams A and C and stigmalactam* 158
Fissistigma glaucescens138aristolactams AII, BII and BIII, goniothalactam and piperolactam A
Fissistigma oldhamii171aristolactams AII, AIIIa, BII, BIII and FII, enterocarpam I, goniothalactam, piperolactams A and C and stigmalactam 158
![]() | ||
15.7 Azafluoranthenes and related tropolones
Syntheses of the tropolone alkaloids imerubrine, isoimerubrine and grandirubrine have been achieved starting from 5,6,7-trimethoxyisoquinoline, following a successful synthesis of colchicine by similar methods (section 18). The isoquinoline 159a was converted through 159b, into the Reissert compound 160a, which was reduced and hydrolysed to 160b and this was converted by stages into the furan 161. A [4+3]cycloaddition of 3,3-dimethoxy-2-trimethylsilyloxypropene to 161 yielded a mixture of the adducts 162a and 163 and of these 162a suffered a ready elimination to the tropolone ether imerubrine 164, though a similar reaction could not be achieved with 163. Reaction of the furan 161 with 1,1,3-trichloropropanone, followed by reduction, gave the bridged cycloheptenone 165, from which the oxygen was eliminated to give the cycloheptatrienone 166. Oxidation of 165 with phenyliodineIII diacetate in methanolic potassium hydroxide afforded the dimethyl ketal of 162b, which was hydrolysed to 162b and elimination of the oxygen bridge from this yielded grandirubrine 167a. Methylation of grandirubrine afforded a mixture of imerubrine 164 and isoimerubrine 167b. O-Methylation of the dimethyl ketal of 162b, followed by hydrolysis, afforded a route to 162a without the formation of 163.175
![]() | ||
![]() | ||
Pallidine, norpallidine and O-methylflavinantine have been isolated from Annona purpurea23 and O-methylflavinantine has also been isolated from Croton menthodorus.176 Hyserpine, a new alkaloid that may be regarded as a degradation product of hasubanonine, isolated from Hyserpa neocaledonica, is described in section 20.
Methods of estimating morphine,177–179 esters of morphine,180 buprenorphine,181,182 norbuprenorphine,182 naltrexone183 and naltrexol183 have been described.
Photochemical N-demethylation of 14-acetoxycodeinone 168a in the presence of oxygen and tetraphenylporphin has been achieved with O,N-acyl migration to give N-acetyl-14-hydroxycodeinone 168b.184 1-Fluorocodeine 169a and 1-fluorodihydrocodeine have been prepared by the thermolysis of the diazonium fluoroborates derived from 1-aminocodeine 169b and 1-aminodihydrocodeine.185 The 3-hydroxy group in morphine has been replaced by a series of amino groups. Morphine 170a was converted into the 3,6-tert-butyldiphenylsilyl ether 170b, which was hydrolysed to the 6-ether 170cc. The trifluoromethanesulfonyl
ester of this 171, on heating with amines and sodium tert-butoxide suffered replacement of the ester group and desilylation of the products yielded the 3-amino-3-deoxymorphines 172a–172e.186 Oxidation of 3-O-methylnaloxone with ammonium ceriumIII nitrate has given 10
-hydroxy-3-O-methylnaloxone 173 which on further oxidation yielded 10-oxo-3-O-methylnaloxone 174a, which was demethylated to 10-oxonaloxone 174b.187 The preparation and use of these compounds and their 14-deoxy analogues has been covered by a patent.188 The 14-aminodihydrocodeinone derivative 175a has been converted
through 175b into 175c, the phenyltetrazolyl ether of which was cleaved to give 176. This was hydrolysed and converted into the amide 177.189
![]() | ||
![]() | ||
![]() | ||
Photochemical oxidation of thebaine affords the enedione-aldehyde 180 together with a smaller amount of the benzofuran 181. These compounds are believed to arise by the addition of singlet oxygen to the diene system of the alkaloid to give 178, which collapses through the related iminium salt to the enamine 179, followed by hydrolysis to 180. This enedione is stable to heat and is converted into the benzofuran 181 by a non-oxidative photochemical cleavage rather than by a retro Diels–Alder reaction. The enedione 180 is reduced by sodium borohydride in methanol to both diastereoisomers of the triol 182, catalytically to the alcohol 183 and finally to the isomers of the triol 184a, and by sodium borohydride and boron trifluoride to the alcohols 184b and 184c. The acetal 185 has been isomerised to the ketal 186, also available directly from 180, which is reduced by sodium borohydride to the disatereoisomeric alcohols 187. Sodium borohydride and boron trifluoride reduce the cis-diol 182 to a mixture of the cis-diol 184c and the alcohol 188. Although the 6,14-peroxide 178 has not been isolated from the oxidation of thebaine its quaternary N-methyl trifluoromethanesulfonate, which is stable at room temperature over an extended period, has been obtained by the photo-oxidation of N-methylthebaine trifluoromethanesulfonate. This peroxide is converted by warm trifluoroacetic acid into the quaternary salt 189b of 14-hydroxycodeinone and the hydroperoxide 189a has been spectroscopically identified as an intermediate in this hydrolysis.190
![]() | ||
![]() | ||
![]() | ||
The 7
-ketone 190 and its 7
-epimer have been equilibrated to a 2
1 mixture of the two by perchloric acid. The related tert-butyl ketones are similarly equilibrated to an equimolecular mixture. This equilibration occurs during the Schmidt reaction of the ketone 190 with perchloric acid and sodium azide, which gives a 2
1 mixture of the amide 191 and its 7
-isomer.191
![]() | ||
Details of the preparation of the following have been published: morphine 6-glucuronide,192 dihydromorphinone,193 dihydrocodeinone,193 14-hydroxycodeinone,190 14-hydroxydihydrocodeinone,194 hydrazones of general structure 192, derived from N-aminonorcodeine,195 naltrexone O,O-distearate196 the amide 193, derived from
-naltrexamine,197 pyrroles of general structures 194a and 194b,198 the indoles 195199 and 196,200 thiophenes, pyridines and quinolines of general structures 197,201198, 199,202 and 200,203 the normorphine derivative 201,204 dehydrobuprenorphine 202,205 alkyl ethers of alcohols of general structure 203,206 the phenols 204207 and 205,208 the amides 206, 207,209 and 208210 and the quaternary indolinodeoxycodeine salt 209.211
![]() | ||
![]() | ||
![]() | ||
![]() | ||
![]() | ||
![]() | ||
![]() | ||
Alternative approaches to intermediates in previously reported syntheses of morphine and its derivatives have been discussed,212–214 and syntheses of the alkaloid have been reviewed.215,216
The analgesic properties,217–277 the pharmacokinetics and the metabolism278–281 of morphine have been studied, as have the effects of the alkaloid on behaviour,234,282–295 on immune responses,296–301 on the brain,302 on the cardiovascular system,303,304 on the gastrointestinal tract,305–309 on neurones,310–316 on blood cells,317–320 on the regulation of temperature,321,322 on respiration,323 on locomotor activity,324,325 on the intake of food,326 on the thalamus,327 on the pituitary gland,301 on the spinal cord,328 and spinal injuries,329 on lung receptors,330 on the foetus,331 on the newborn,332 on the utilisation of glucose,333 on the intake of saccharin,334 on pruritus,335,336 on peritonitis,337 on feline immunodeficiency virus,338 on intracellular pH,339 on macrophage apoptosis,340 on calcium channels,341 on adrenoreceptors,342 on nicotinic receptors,343 on messenger RNA,344–346 on nitrite production,347–349 on gene expression,350,351 on susceptibility to Salmonella typhimurum,352 on levels of dopamine,353 of opioid peptides,354 of calcitonin,355 of corticosterone,356 of interleukins,356,357 of oxytocin358,359 and of substance P355 and on the effects of apomorphine,360 of amikacin,361 of caffeine,362 of cocaine,363 of N-methyl-3,4-methylenedioxyamphetamine,363 and of naloxone.364
The morphine-antagonist actions of naloxone have been studied,365–369 as have the effects of this compound on behaviour,366 on the development of tolerance to morphine,370 on neurones,371–375 on brain injuries,376 on cerebral blood flow,377 on reflexes,378,379 on the spinal cord,380 on the cardiovascular system,381 on lactate and pyruvate metabolism,382 on antoxidant enzyme activity,382 on levels of adrenocorticotropin,383 and of dopamine,384 and on the effects of amikacin,361 of buprenorphine,385 of diazepam,386 of methotrexate386 and of pentobarbital.386
The pharmacological properties and physiological effects of the following have also been studied: O,O-diacetylmorphine (heroin),387–404 morphine 3-glucuronide,278,405 morphine 6-glucuronide,278,326,406,407 dihydromorphinone,408,409 14-hydroxydihydromorphinone,410 codeine,411–418 dihydrocodeinone,417 naltrexone,410,419–431 methylnaltrexone,432 naloxone benzylhydrazone,433 nalbuphine,434–436 nalmefene,437–441 naltrindole,442 5
-guanidinonaltrindole,443 7
-(2,3-diformylphenylcarboxamido)naltrindole [7
-(phthalaldehydecarboxamido)naltrindole],444
-funaltrexamine,445 norbinaltorphimine,446 etorphine,447,448 dihydroetorphine,449,450 buprenorphine,434,451–459O-methylflavinantine,176 and (+)-morphine.460
A review of the use of opiates in medicine has also been published.461
(R)-Homolaudanosine 21e has been synthesised from 19e as described in section 2.25
Atropisomeric colchicinoids have been prepared for the first time. Isocolchicine 210a and its relatives 210b and 210c, on treatment with ammonia and with amines, gives the atropisomeric amines 211 and 212, which in some cases are stable and in others are rapidly equilibrated. The isomers have been distinguished by their dichroic properties. Colchicine 213a, under similar conditions, affords the regioisomeric amines 214 and 215.462
![]() | ||
![]() | ||
9-Tolylsulfonyloxycolchicoside 210c reacts rapidly with the anion of dimethyl malonate in dimethyl sulfoxide to give the lactone 216, whereas the isomeric 10-tolylsulfonyloxy compound 213b reacts very slowly under identical conditions to give the isomeric lactone 217. Neither of these reactions occurs in hydroxylic solvents.463
![]() | ||
A synthesis of colchicine 213a has been achieved from the alcohol 218a. This was converted into the acetylene 218b which was converted into the oxazole 219a and this was further converted through 219b and 219c into the furan 220a, also available by an alternative, though similar, route. The furan 220a was converted into the related 220b, which underwent a [4+3]cycloaddition reaction with the
-methoxytrimethylsilyloxyallyl cation (generated in situ from the trimethylsilyl enol ether of pyruvic aldehyde) to give 221. This was
smoothly cleaved to N-benzyloxycarbonyl-N-deacetylcolchicine, which was hydrolysed and acetylated to give colchicine 213a. The furan 220a also underwent [4+3]addition of 3,3-dimethoxy-2-trimethylsilyloxypropene, but the undesired regioisomer 222 was the sole product of the reaction.464
![]() | ||
A patent for the preparation of ring-contracted colchinoids similar to colchibiphenyline 223a and salimine 223b of general structure 223 has been published.465
![]() | ||
The physiological effects and other properties of colchicine have been studied.466–477
19.1 Erythrinanes
The isomeric 15 and 16
-D-glucosides of erysopine have been isolated for the first time, together with erysodine
-D-glucoside, erysotramidine, erysotrine, erysovine, erythraline and 8-oxoerythraline, from Erythrina latissima.478
A modified synthesis of (±)-erysotrine 228, with a three-fold increase in overall yield, has been reported. Diels–Alder addition of the dioxopyrroline 224 to 1-methoxy-3-trimethylsilyloxybutadiene, followed by reduction of the adduct with lithium borohydride and hydrolysis, afforded the erythrinane 225, which was converted into 226. Reduction of this with sodium borohydride gave the 3
-alcohol 227a and its 3
-isomer in a 9
1 ratio. O-Methylation of 227a gave (±)-erysotramidine 227b, which was reduced by lithium aluminium hydride to (±)-erysotrine 228. Peracid oxidation of 227a yielded the 4,5
-epoxide 229a, the methyl ether of which 229b was converted by samariumII iodide into the allylic alcohol 230, which was reduced by lithium aluminium hydride and aluminium chloride to (±)-erythatidine 231 (80%) and (±)-erysotrine 228 (16%). The epoxide 229b could not be prepared from erysotramidine 227b The dienone 226 was oxidised by alkaline hydrogen peroxide to the 4,5
and 4,5
epoxides, which were reduced to 229a and its 3
-epimer and to the 4,5
-epoxide isomers of these alcohols.479
![]() | ||
![]() | ||
In a new approach to the erythrinane ring system the methylthioacetamide 232 has been oxidised by manganese dioxide in the presence of copperII acetate to give a mixture of 233 and 234, whereas in the presence of copperII trifluoromethanesulfonate the product was the saturated erythrinane 235.480
![]() | ||
The effects of
-erythroidine and of dihydro-
-erythroidine on behaviour have been studied.481
19.2 Homoerythrinanes
3-Epischellhammericine and 3-epitaxodine have been isolated from Cephalotaxus harringtonia.482
19.3 Cephalotaxine and related alkaloids
Cephalotaxine, 11-hydroxycephalotaxine, demethylcephalotaxinone, drupacine, harringtonine, deoxyharringtonine, homodeoxyharringtonine, isoharringtonine and the new alkaloids cephalezomine A 236a, cephalezomine B 236b, cephalezomine C 237a, cephalezomine D 237b, cephalezomine E 238a and cephalezomine F 238b have been isolated from Cephalotaxus harringtonia. The structures of the new alkaloids were deduced from their spectra.482 The mono- and di-acetyl esters of 11-hydroxycephalotaxine have been prepared.483 An improved preparation of the
-keto-acid 239, an intermediate in the synthesis of homoharringtonine,
has been reported.484
![]() | ||
![]() | ||
The physiological and antitumour effects of homoharringtonine have been studied.485,486
Hyserpine 240, which is not an isoquinoline but which can be regarded as a degraded hasubanonine, has been isolated from Hyserpa neocaledonica.487
Buzonamine, a defensive secretion of the millipede Buzonium crassipes, has been assigned the octahydroisoquinoline structure 241.488
![]() | ||
Antidesmone, from Antidesmona membranaceum and A. venosum, originally assigned the tetrahydroisoquinoline structure 242, has been shown to be the pyridone 243.489
![]() | ||
Syntheses of aaptamine 244a, N-methylaaptamine 244b, isoaaptamine 245a and its regioisomer 245b have been reported.490
![]() | ||
Jorumycin 246, which is a relative of the saframycins, has been isolated from the marine organism Jorunna funebris.491 It is a cytotoxic agent slightly less potent than the related ecteinascidin E743 247. Syntheses of analogues of the saframycins492,493 and ecteinascidins494 and a synthesis of ecteinascidin E743 247 from cyanosafracin B495 have been reported.
![]() | ||
| 1 | S. Sang, S. Mao and A. Lano, Zhongcaoyao, 2000, 31, 244 | |
| 2 | F. R. Chang, C. Y. Chung, T. J. Hsieh, C. P. Cho and Y. C. Wu, J. Chin. Chem. Soc. (Taipei), 2000, 47, 913 | |
| 3 | T. S. Wu, Y. Y. Chan and Y. L. Leu, J. Nat. Prod., 2001, 64, 71 [Links]. | |
| 4 | S. D. Sarkar, B. Bartholomew and R. J. Nash, Fitoterapia, 2000, 71, 328 [Links]. | |
| 5 | B. M. G. Claros, A. S. R. da Silva, M. L. A. A. Vasconcellos, A. P. P. de Brito and G. G. Leitao, Phytochemistry, 2000, 55, 859 [Links]. | |
| 6 | H. Y. Lin, C. H. Chen, K. C. S. C. Liu and S. Lee, J. Nat. Prod., 2000, 63, 1388 [Links]. | |
| 7 | R. Starha, A. Chybidziurova and Z. Lancy, Acta Univ. Palacki. Olomuc., Fac. Rerum Nat. Chem., 1999, 38, 71, (Chem. Abstr., 2000, 133, 347094) | |
| 8 | S. Liu, I. L. Tsai, T. Ishikawa, T. Hayarama and I. S. Chen, J. Chin. Chem. Soc. (Taipei), 2000, 47, 571 | |
| 9 | F. Rose-Munch, R. Chavignon, J.-P. Tranchier, V. Gagliardini and E. Rose, Inorg. Chim. Acta, 2000, 300, 693 [Links]. | |
| 10 | Z. Cen and S. Cai, Huagong Xuebao (Chin. Ed.), 2000, 51, 418 | |
| 11 | G. T. Baramysova, B. Zh. Dzhimbaev and K. D. Praliev, Izv. Minist. Nauki Vyssh. Obraz. Resp. Kaz. Nats. Akad. Nauk Resp. Kaz. Ser. Khim., 1999, 28, (Chem. Abstr., 2000, 133, 4832) | |
| 12 | G. T. Baramysova, B. Zh. Dzhimbaev, K. D. Praliev and B. V. Rozhnov, Izv. Minist. Nauki
Vyssh. Obraz. Resp. Kaz. Nats. Akad. Nauk. Resp. Kaz. Ser. Khim., 1999, 81, (Chem. Abstr., 2000, 133, 4833) | |
| 13 | J. Ermert, K. Hamancher and H. H. Coenen, J. Labelled Compd. Radiopharm., 2000, 43, 1345 [Links]. | |
| 14 | G. Amyard, B. Labarthe, D. Warot, I. Berlin and B. Diquet, J. Chromatogr. B.
Biomed. Sci. Appl., 2000, 744, 25 | |
| 15 | M. Mori, H. Yamamoto, S. Hattori, H. Miyakawa and T. Noguchi, Anaesthesia, 2000, 55, 523 [Links]. | |
| 16 | J. T. Cheng, I. M. Liu, S. T. Yen, S. W. Juang, T. P. Liu and P. Chan, Auton. Neurosci., 2001, 88, 1 [Links]. | |
| 17 | S. B. Karch, Toxicol. Clin. Pharmacol. Herb. Prod., 2000, 11 | |
| 18 | H. Shibata, E. Minami, R. Hirata, N. Mizutani, T. Nabe and S. Kohno, Inflammation Res., 2000, 49, 553 | |
| 19 | N. D. Gill, A. Shield, A. J. Blazevich, S. Zhou and R. P. Weatherby, Br. J. Clin. Phamacol., 2000, 50, 205 | |
| 20 | D. McD. Taylor, K. S. O'Toole, T. Auble, C. M. Ryan and D. R. Sherman, Pharmacotherapy, 2000, 20, 1045 | |
| 21 | L. C. Strindelius, R. L. Nation, A. M. Evans, J. L. Cabot and K. M. Corbett, Clin. Exp. Pharmacol. Physiol., 2001, 28, 43 [Links]. | |
| 22 | A. Itoh, Y. Ikuta, T. Tanahashi and N. Nagakura, J. Nat. Prod., 2000, 63, 723 [Links]. | |
| 23 | F. R. Chang, C. Y. Chen, P. H. Wu, R. Y. Kuo, Y. C. Chang and Y. C. Wu, J. Nat. Prod., 2000, 63, 746 [Links]. | |
| 24 | T. Schwimming, K. Jenett-Smith, K. Siems, L. Witte, M. P. Gupta and E. Eich, Z. Naturforsch. C: J. Biosci., 2000, 55, 1023 | |
| 25 | R. Pedrosa, C. Andrés and J. M. Iglesias, J. Org. Chem., 2001, 66, 243 [Links]. | |
| 26 | D. Taniyama, M. Hasegawa and K. Tomioka, Tetrahedron Lett., 2000, 41, 5533 [Links]. | |
| 27 | A. J. Burton, J. P. Graham and N. S. Simpkins, Synlett, 2000, 1640 [Links]. | |
| 28 | T. S. Kaufman, Heterocycles, 2001, 55, 323 | |
| 29 | T. Honda, H. Namiki and F. Satoh, Org. Lett., 2001, 3, 631 [Links]. | |
| 30 | G. Bringmann, A. Hamm, G. Günther, M. Michel, R. Brun and V. Mudugo, J. Nat. Prod., 2000, 63, 1465 [Links]. | |
| 31 | G. Bringmann, G. Günther, W. Saeb, J. Mies, A. Wickramasinghe, V. Mudugo and R. Brun, J. Nat. Prod., 2000, 63, 1333 [Links]. | |
| 32 | C. P. Tang, Y. P. Yang, Y. Zhong, Q. Zhong, H. M. Wu and Y. Ye, J. Nat. Prod., 2000, 63, 1384 [Links]. | |
| 33 | G. Bringmann, C. Günther, W. Saeb, J. Mies, R. Brun and L. A. Assi, Phytochemistry, 2000, 54, 337 [Links]. | |
| 34 | G. Bringmann, W. Saeb, J. Wohlfarth, K. Messer and R. Brun, Tetrahedron, 2000, 56, 5871 [Links]. | |
| 35 | G. Bringmann, W. Saeb, J. Kraus, R. Brun and G. Francois, Tetrahedron, 2000, 56, 3523 [Links]. | |
| 36 | G. Bringmann, W. Saeb, J. Mies, K. Messer, M. Wohlfarth and R. Brun, Synthesis, 2000, 1843 [Links]. | |
| 37 | K. Kamikawa, T. Watanabe, A. Daimon and M. Uemura, Tetrahedron, 2000, 56, 2325 [Links]. | |
| 38 | T. Watanabe, M. Shakadou and M. Uemura, Synlett, 2000, 1141 [Links]. | |
| 39 | G. Bringmann, C. Günther and E.-M. Peters, Tetrahedron, 2001, 57, 1253 [Links]. | |
| 40 | J. J. Chen, Y. Y. Chang, C. M. Teng and I. S. Chen, Planta Med., 2000, 55, 133 | |
| 41 | R. S. Istatkova and S. A. Philipov, Phytochemistry, 2000, 54, 959 [Links]. | |
| 42 | S. Jumana, C. M. Hasan and M. A. Rashid, Biochem. Syst. Ecol., 2000, 28, 483 [Links]. | |
| 43 | Y. Nishiyami, M. Moriyasu, M. Ichimaru, K. Iwasa, A. Kato, S. G. Mathenge, P. B. C. Mutiso and F. D. Juma, Nat. Med. (Tokyo), 2000, 54, 338 | |
| 44 | A. Sari and G. Sariyar, Pharmazie, 2000, 55, 471 | |
| 45 | S. Nimgirawath, Aust. J. Chem., 2000, 58, 523 [Links]. | |
| 46 | T. Honda, M. Nishimura, J. Itabishi and K. Kazuo, Heterocycles, 2000, 53, 1121 | |
| 47 | A. R. Hajipour and M. Hantehzadeh, Phosphorus, Sulfur, Silicon Relat. Elem., 2000, 161, 181 | |
| 48 | S. Ruchiwarat and T. Mutarapat, Tetrahedron Lett., 2001, 42, 1205 [Links]. | |
| 49 | K. Shimizu, T. Ichikawa, N. Urakawa and S. Nakajyo, Jpn. J. Pharmacol., 2000, 83, 143 | |
| 50 | T. Shimizu, Y. Ohta, H. Ozawa, H. Matsushima and K. Takeda, Anticancer Res., 2000, 20, 761 | |
| 51 | J. S. Shin, J. J. Lee, Y. Kim, C. K. Lee, Y. P. Yun and M. K. Lee, Biol. Pharm. Bull., 2001, 24, 103 | |
| 52 | R. de, A. Ribeiro and G. R. De Lores Arnaiz, Phytomedicine, 2000, 7, 313 | |
| 53 | A. Anthony, D. Chemla, G. Lerebours and A. Nitenberg, J. Cardiovasc. Pharmacol., 2000, 36, 570 [Links]. | |
| 54 | R. Chandra, R. Aneja, C. Rewal, R. Conduri, S. K. Dass and S. Agarwal, Indian J. Clin. Biochem., 2000, 15, 155 | |
| 55 | A. J. Soppitt, P. S. A. Glass, H. El-Moalem, B. Ginsberg, K. Weatherwax and I. J. Gan, J. Clin. Anesth., 1999, 11, 657, (Chem. Abstr., 2000, 133, 38051) [Links]. | |
| 56 | C. V. Lowenick, K. Krampfl, H. Schneck, E. Kochs and J. Bufler, Eur. J. Pharmacol., 2001, 413, 31 [Links]. | |
| 57 | A. Ortega, C. Sarobe, M. J. Iribarren and J. Giraldez, Pharm. World Sci., 2000, 22, 82 [Links]. | |
| 58 | V. Mahiou, F. Roblot, A. Fournet and R. Hocquemiller, Phytochemistry, 2000, 54, 709 [Links]. | |
| 59 | L. Mambu, M. T. Martin, D. Razafimahefa, D. Daminitrasimbola, P. Rasonaivo and F. Frappier, Planta Med., 2000, 66, 537 [Links]. | |
| 60 | M. Menachery, E. W. Stern, R. J. Steinbeiser, A. J. Freyer and L. B. Killmer, Tetrahedron Lett., 2000, 41, 2843 [Links]. | |
| 61 | F. Z. Erdemgil, M. V. Telezhenetskaya, K. H. C. Baser and N. Kirimer, Chem. Nat. Compd., 2000, 36, 223 | |
| 62 | P. L. Schiff, Alkaloids Chem. Biol. Perspect., 1999, 14, 1, (Chem. Abstr., 2000, 133, 89663) | |
| 63 | J. Li, S. Zhang, G. Yang, Q. Xiao, Y. Wang and K. Zhang, Zhongguo Yaolixue Tongbao, 1999, 15, 542, (Chem. Abstr., 2000, 133, 53466) | |
| 64 | M. Miyagawa, T. Shirotori, E. Ohta, Y. Ishige, F. Mizumo, M. Akasu and M. Ono, Iyakuhin Kenkyu, 2000, 31, 1 | |
| 65 | N. Sogawa, C. Sogawa and H. Furuta, Igaku to Seibutsugaku, 2000, 140, 69 | |
| 66 | Z. Wang, K. Li and X. Xiao, Zongguo Yaolixue Tongbao, 2000, 16, 199 | |
| 67 | L. Shi and Z. Liu, Zhongguo Yaowu Yilaixing Zazhi, 2000, 9, 106 | |
| 68 | J. Chen, Z. Wu, S. Chen, X. Gong, J. Zhong and G. Zhang, Jpn. J. Physiol., 1999, 48, 499, (Chem. Abstr., 2000, 133, 37966) | |
| 69 | Z. F. Wang, C. S. Xue, Q. X. Zhou, Z. B. Wan and Q. S. Luo, Zhongguo Yaolixue Yu Dulixue Zazhi, 2000, 14, 58 | |
| 70 | H.
L. Wang, S. A. Kilfeather, G. R. Martin and C. P. Page, Pulm. Pharmacol. Ther., 2000, 13, 53 | |
| 71 | D. Zeng, M. Zhao, W. Liu and X. Lu, Zhonghua Chuangshan Zazhi, 2000, 16, 367 | |
| 72 | Y. H. Zhang and L. H. Fang, Planta Med., 2001, 67, 77 [Links]. | |
| 73 | H. Meng, D. Zhang, M. Song and L. Zhang, Zhongguo Yike Daxue Xuebao, 2000, 29, 247 | |
| 74 | C. Y. Kwan, Y. M. Leung, T. K. Kwan and E. E. Daniel, Life Sci., 2001, 68, 841 [Links]. | |
| 75 | W. B. Liu, G. Q. Liu, H. Xiao, X. Mao, Y. Shi and J. P. Wu, Acta Pharmacol. Sin., 2000, 21, 1115 | |
| 76 | T. M. Wong, S. Wu, X. C. Yu and H. Y. Li, Acta Pharmacol. Sin., 2000, 21, 1083 | |
| 77 | P. H. Park, J. X. Nan, E. J. Park, H. C. Kang, J. Y. Kim, K. Go and D. H. Sohn, Pharmacol. Toxicol. (Copenhagen), 2000, 87, 261 | |
| 78 | Z. H. Liu, N. Li, J. L. Li and L. M. Shi, Zhongguo Yaolixue Yu Dulixue Zazhi, 2000, 14, 258 | |
| 79 | L. Y. Chen, X. Chen, X. L. Tian and X. H. Yu, Br. J. Pharmacol., 2000, 131, 530 | |
| 80 | N. Zhong and J. Qian, Zhongguo Yaolixue Tongbao, 2000, 16, 282 | |
| 81 | A. Khasnobis, T. Seal, J. Vedrasiromoni, M. Gupta and B. Mukherjee, Nat. Prod. Sci., 2000, 6, 44 | |
| 82 | G. P. Joshi, A. Hailey, S. Cross, G. Thompson-Bell and C. C. Whitten, J. Clin. Anesth., 1999, 11, 641, (Chem. Abstr., 2000, 133, 38050) [Links]. | |
| 83 | C. Ibebunjo and J. A. J. Martin, Anesth. Analg. (Baltimore), 2000, 91, 1243 | |
| 84 | L. M. Tagliari and W. Alves-do-Prado, Acta Sci., 1998, 20, 231, (Chem. Abstr., 2001, 134, 188092) | |
| 85 | M. Mikat-Stevens, R. Sukharni, P. Radha, L. Ana, E. Fluder, B. Kleinman and R. A. Stevens, Anesth. Analg. (Baltimore), 2000, 91, 312 | |
| 86 | K. Orito, R. Harada, S. Uchito and M. Tokuda, Org. Lett., 2000, 2, 1799 [Links]. | |
| 87 | S. Ruchiwarat and A. Namsa-aid, Tetrahedron Lett., 2001, 42, 1359 [Links]. | |
| 88 | K. Orito, Y. Satoh, H. Nishizawa, R. Harada and M. Tokuda, Org. Lett., 2000, 2, 2535 [Links]. | |
| 89 | H. Xu, Zhongguo Zhongyao Zazhi, 2000, 25, 486 | |
| 90 | Y. C. Chang, F. R. Chang and Y. C. Wu, J. Chin. Chem. Soc. (Taipei), 2000, 47, 373 | |
| 91 | C. Y. Chen, F. R. Chang, Y. C. Shih, T. J. Hsieh, Y. C. Chia, H. Y. Tseng, H. C. Chen, S. J. Chen, M. C. Hsu and Y. C. Wu, J. Nat. Prod., 2000, 63, 1475 [Links]. | |
| 92 | I. M. F. Sette, E. V. L. da-Cunha, J. M. Barbosa-Filho, M. de Fatima Agra and M. S. da-Silva, Biochem. Syst. Ecol., 2000, 28, 393 [Links]. | |
| 93 | I. M. F. Sette, E. V. L. da-Cunha, J. M. Barbosa-Filho and M. S. da-Silva, Pharm. Biol. (Lisse, Neth.), 2000, 38, 318 | |
| 94 | C. W. Lin, J. U. Su, L. M. Zeng, W. L. Peng and A. N. Xu, Goadeng Xuexiao Huaxue Xuebao, 2000, 21, 1820 | |
| 95 | A. Laguna and M. Fajardo, Rev. CENIC, Cienc. Quim., 1999, 30, 92, (Chem. Abstr., 2000, 133, 220212) | |
| 96 | M. O. Iwunze, Monatsh. Chem., 2000, 131, 429 [Links]. | |
| 97 | S. Komorsky-Lovric, Electroanalysis, 2000, 12, 599 [Links]. | |
| 98 | R. Suau, F. Nájera and R. Rico, Tetrahedron, 2000, 56, 9713 [Links]. | |
| 99 | K. Orito, M. Miyazawa, R. Kanbayashi, T. Tatsuzawa, M. Tokuda and H. Suginome, J. Org. Chem., 2000, 65, 7495 [Links]. | |
| 100 | D. A. Bianchi and T. S. Kaufman, Can. J. Chem., 2000, 78, 1165 [Links]. | |
| 101 | H. Zhou and S. Mineshita, J. Pharmacol. Exp. Ther., 2000, 294, 822 | |
| 102 | D. L. Dong, J. P. Sun, D. L. Luo, Q. W. Chen, F. Wang, S. Z. He and F. F. Yang, Zhongguo Yaolixue Yu Dulixue Zazhi, 2000, 14, 128 | |
| 103 | P. Hu and C. Zhang, Tianan Yiyao, 2000, 28, 164 | |
| 104 | B. X. Li, B. F. Yang, J. Zhou, C. Q. Xu and Y. R. Li, Acta Pharmacol. Sin., 2001, 22, 125 | |
| 105 | P. Krishnan and K. F. Bastow, Anti-Cancer Drug Des., 2000, 15, 255 | |
| 106 | J. Y. Cao, H. S. Luo, B. P. Yu, Z. X. Sheng and J. P. Yu, Shengli Xuebao, 2000, 52, 343 | |
| 107 | Y. Hao, Q. Y. Qiu, J. J. Wang and J. Wu, Zhongguo Bingli Shengli Zazhi, 2000, 16, 585 | |
| 108 | L. Orfila, M. Rodriguez, T. Colman, M. Hasegawa, E. Merentes and F. Arvelo, J. Ethnopharmacol., 2000, 71, 449 [Links]. | |
| 109 | E. K. Marinova, D. B. Nikolova, D. N. Popova, G. B. Gallacher and N. D. Ivanovska, Immunopharmacology, 2000, 48, 9 [Links]. | |
| 110 | X. L. Jin, Y. Shao, M. J. Wang, L. J. Chen and G. Z. Jin, Acta Pharmacol. Sin., 2000, 21, 477 | |
| 111 | W. Zhang, J. Zhi, W. Gou, R. Zhao and G. Jin, Zhongguo Zhongyao Zazhi, 2000, 25, 497 | |
| 112 | Z. T. Zhu, Y. Fu, G. Y. Hu and G. Z. Jin, Life Sci., 2000, 67, 11 [Links]. | |
| 113 | Y. Ren and K. Zang, Zhongguo Yaowu Yilaixing Zazhi, 2000, 9, 108 | |
| 114 | S. H. Xing, Y. Gao and C. F. Bian, Asia Pac. J. Pharmacol., 1998, 13, 155, (Chem. Abstr., 2000, 133, 479) | |
| 115 | M. T. Hsieh, Res. Commun. Pharmacol. Toxicol., 1999, 4(III), 1 | |
| 116 | Y. Li, L. Cheng, W. Yao and G. Xia, Yaoxue Xuebao, 2000, 35, 85 | |
| 117 | L. G. Kintsurashvili and V. Yu. Vachnadze, Chem. Nat. Compd., 2000, 35, 225 | |
| 118 | J. A. Knapp and Y. Key, PCT Int. Appl. WO 00 64446 (Chem. Abstr., 2000, 133, 335375) | |
| 119 | R. Razet, U. Thomet, R. Furtmuller, F. Jursky, E. Sigel, W. Sieghart and R. H. Dodd, Bioorg. Med. Chem. Lett., 2000, 10, 2579 [Links]. | |
| 120 | K. K. Sharma, P. K. Mediratta and S. P. Dubey, Indian J. Pharmacol., 2000, 32, 327 | |
| 121 | S. Pilip, E. W. Urbanska, M. Swiader, D. Woldarczyk, Z. Kleinrok, S. J. Czuczwar and W. A. Turski, Pol. J. Pharmacol., 2000, 52, 267 | |
| 122 | K. Rejdak, R. Rejdak, Z. Kleinrok and M. Sieklucka-Dziuba, J. Neural Transm., 2000, 107, 947 [Links]. | |
| 123 | B. Gozlinska and H. Czyzewska-Szafran, Res. Commun. Mol. Pathol. Pharmacol., 1999, 106, 13, (Chem. Abstr., 2001, 134, 141561) | |
| 124 | C. Bruckner, K. Stenkamp, H. Meierkord and U. Heinemann, Neurosci. Res. Commun., 2000, 26, 41 [Links]. | |
| 125 | Y. Q. Jin, S. M. Duan, J. Wang and Y. M. Zeng, Zhongguo Yaolixue Yu Dulixue Zazhi, 2000, 414, 287 | |
| 126 | B. Birnir, M. Eghbali, A. B. Everitt and P. W. Gage, Br. J. Pharmacol., 2000, 131, 695 | |
| 127 | D. K. Kim and T. Y. Shin, Arch. Pharmacal. Res., 2000, 23, 459 | |
| 128 | D. K. Kim, J. S. Eun, T. Y. Shin, D. O. Eom and J. P. Lim, Arch. Pharmacal. Res., 2000, 23, 589 | |
| 129 | P. Krajewski and J. Sitkowski, Magn. Reson. Chem., 2000, 38, 757 [Links]. | |
| 130 | A. R. Jalilian, P. Seyfi, H. Afarideh and A. Shafiee, Appl. Radiat. Isot., 2001, 54, 407 | |
| 131 | T. Akiyama, N. Toshihiko, Y. Nakano, K. Shibaike, H. Akamatsu and T. Harayama, Tennen Yuki Kakobutsu Koen Yoshishu 42nd., 2000, 709, (Chem. Abstr., 2001, 134, 340579) | |
| 132 | T. Harayama, H. Akamatsu, K. Okamura, T. Miyagoe, T. Akiyama, H. Abe and Y. Takeuchi, J. Chem. Soc., Perkin Trans. 1, 2001, 523 [Links]. | |
| 133 | T. Harayama, T. Akiyama, H. Akamatsu, K. Kawano, H. Abe and Y. Takeuchi, Synthesis, 2001, 444 [Links]. | |
| 134 | W. J. Cho, I. J. Kim and S. J. Park, Bull. Korean Chen. Soc., 2000, 21, 1035 | |
| 135 | B. Tian, L. C. Brumback and P. L. Kaufman, Exp. Eye Res., 2000, 71, 551 [Links]. | |
| 136 | G. Scheiner-Bobis, Naunyn-Schmiedeberg's Arch. Pharmacol., 2001, 363, 203 | |
| 137 | C. M. Hu, H. W. Cheng, Y. W. Cheng and J. J. Kang, Jpn. J. Pharmacol., 2001, 85, 47 | |
| 138 | W. L. Lo, F. R. Chang and Y. C. Wu, J. Chin. Chem. Soc. (Taipei), 2000, 47, 1251 | |
| 139 | M. H. H. Nkunya, S. A. Jonker, J. J. Makangara, R. Waibel and H. Aschenbach, Phytochemistry, 2000, 53, 1067 [Links]. | |
| 140 | C. M. Hasan, S. Jumana and M. A. Rashid, Nat. Prod. Lett., 2000, 14, 393 | |
| 141 | M. Del Rayo Camacho, G. C. Kirby, D. C. Warhurst, S. L. Croft and J. D. Phillipson, Planta Med., 2000, 66, 478 [Links]. | |
| 142 | L. H. Tseng, U. Braumann, M. Godejohann, S. S. Lee and K. Albert, J. Chin. Chem. Soc. (Taipei), 2000, 47, 1231 | |
| 143 | N. S. K. Rao and S. S. Lee, J. Chin. Chem. Soc. (Taipei), 2000, 47, 1227 | |
| 144 | S. Nimgirawath and P. Podoy, Aust. J. Chem., 2000, 53, 527 [Links]. | |
| 145 | S. Ruchiwarat and P. Predapitakkun, Heterocycles, 2001, 55, 371 | |
| 146 | R. Kubinova, M. Machala, K. Minksova, J. Neca and V. Suchy, Pharmazie, 2001, 56, 242 | |
| 147 | I. Jimenez and H. Speisky, Phytother. Res., 2000, 14, 254 [Links]. | |
| 148 | Y. Y. Jang, J. H. Song, Y. K. Shin, E. S. Han and C. S. Lee, Pharmacol. Res., 2000, 42, 361 [Links]. | |
| 149 | I. Jimenez, A. Garrido, R. Bannach, M. Gotteland and H. Speisky, Phytother. Res., 2000, 14, 339 [Links]. | |
| 150 | H. Li, R. Zhang, H. Ye and W. Wang, Zhongguo
Zhongyao Zazhi, 2000, 25, 426 | |
| 151 | J. J. Battisti, N. J. Uretsky and L. J. Wallace, Pharmacol. Biochem. Behav., 2000, 66, 671 [Links]. | |
| 152 | D. Farzin and M. Attarzadeh, Eur. J. Pharmacol., 2000, 404, 169 [Links]. | |
| 153 | A. Kask and J. Harro, Neuropharmacology, 2000, 39, 1292 [Links]. | |
| 154 | F. Kamah, Curr. Opin. Cent. Peripher. Nerv. Syst. Invest. Drugs, 2000, 2, 303 | |
| 155 | M. Ohta, I. Mizuta, K. Ohta, M. Nishimura, E. Mizuta, K. Hayashi and S. Kuno, Biochem. Biophys. Res. Commun., 2000, 272, 18 [Links]. | |
| 156 | J. M. Stern and M. Protomastro, Pharmacol. Biochem. Behav., 2000, 66, 353 [Links]. | |
| 157 | J. J. Battisti, N. J. Uretsky and L. J. Wallace, Pharmacol. Biochem. Behav., 2000, 66, 435 [Links]. | |
| 158 | K. Pruus, R. Rudissaar, T. Skrebukhova-Malmros, L. Allikmets and V. Matto, Methods Find. Exp. Clin. Pharmacol., 2000, 22, 47 | |
| 159 | V. Matto, A. Vaarmann, R. Rudissaar, K. Pruus, T. Skrebukhova-Malmos and L. Allikmets, Neurosci. Lett., 2000, 289, 131 [Links]. | |
| 160 | K. Kashihara, Y. Manabe, Y. Shiro, H. Warita and K. Abe, Neurosci. Res. (Shannon, Ireland), 2000, 38, 273 | |
| 161 | V. Matto, A. Vaarmann and L. Allikmets, Pharmacol. Toxicol. (Copenhagen), 2001, 88, 147 | |
| 162 | Z. A. Martinez, J. Oostwegel, M. A. Geyer, G. D. Ellison and M. R. Swerdlow, Neuropsychopharmacology, 2000, 23, 517 [Links]. | |
| 163 | V. Matto, A. Vaarmann, K. Pruus, R. Rudissaar, T. Skrebukhova-Malmos and L. Allikmets, Pharm. Pharmacol. Lett., 2000, 10, 59 | |
| 164 | T. Skrebukhova-Malmos, K. Pruus, R. Rudissaar, L. Allikmets and V. Matto, Pharmacol. Biochem. Behav., 2000, 67, 339 [Links]. | |
| 165 | J. J. Battisti, C. B. Shreffler N. J. Uretsky and L. J. Wallace, Pharmacol. Biochem. Behav., 2000, 67, 241 [Links]. | |
| 166 | R. Dos Santos El-Bacha, J.-L. Daval, V. Koziel P. Netter and A. Minn, Biochem. Pharmacol., 2001, 61, 73 [Links]. | |
| 167 | M. Sherifzadeh, H. R. Sadeghipour, A. R. Dehpour, S. Mahdavi and F. Mohammadpour, Asia Pac. J. Pharmacol., 1999, 14, 1, (Chem. Abstr., 2001, 134, 95360) | |
| 168 | S. I. Iwata, M. Nomoto, S. Kaseda, S. Tanoue, M. Shimosaka and T. Fukuda, Mol. Brain Res., 2000, 82, 133 [Links]. | |
| 169 | J. E. Bolhuis, W. G. P. Schouten, I. C. De Jong, J. W. Schrama, A. R. Cools and V. M. Wiegant, Psychopharmacology (Berlin), 2000, 152, 24 | |
| 170 | R. Dos Santos El-Bacha, S. Leclec, P. Netter, J. Magdalou and A. Minn, Life Sci., 2000, 67, 1735 [Links]. | |
| 171 | T. Linnanen, M. Brisander, N. Mohell and A. M. Johansson, Bioorg. Med. Chem. Lett., 2001, 11, 367 [Links]. | |
| 172 | Y. Chia, F. R. Chang, C. M. Teng and Y. C. Wu, J. Nat. Prod., 2000, 63, 1160 [Links]. | |
| 173 | T. S. Wu, Y. Y. Chan and Y. L. Leu, Chem. Pharm.
Bull., 2000, 48, 1006 | |
| 174 | T. S. Wu, Y. L. Leu and Y. Y. Chan, Biol. Pharm. Bull., 2000, 23, 1216 | |
| 175 | J. C. Lee and J. K. Cha, J. Am. Chem. Soc., 2001, 123, 3243 [Links]. | |
| 176 | A. Capasso, S. Piacente, N. De Tommasi and P. Cosimo, Phytother. Res., 2000, 14, 156 [Links]. | |
| 177 | H. J. Leis, G. Fauler, G. Raspoting and W. Windischofer, J. Chromatogr. B, Biomed. Sci. Appl., 2000, 744, 113 | |
| 178 | A. Goumon, F. Casares, W. Zhu and G. B. Stefano, Mol. Brain Res., 2001, 86, 184 [Links]. | |
| 179 | S. Lu, W. Chang, Y. Li and Y. Ci, Fenxi Huaxue, 2000, 28, 1321 | |
| 180 | K. Otter, C. Mignat, D. Heber and A. Ziegler, Biomed. Chromatogr., 2000, 14, 27 [Links]. | |
| 181 | M. A. Garcia-Fernandez, M. T. Fernandez-Abedul and A. Costa-Garcia, Electroanalysis, 2000, 12, 483 [Links]. | |
| 182 | V. Crimele, P. Kintz, S. Lohner and B. Ludes, J. Anal. Toxicol., 2000, 24, 448 | |
| 183 | K. Sarrka, K. Ariniemi and P. Lillsunde, Z Zagadnien Nauk Sadowych, 2000, 43, 250 | |
| 184 | J. A. Ripper, E. R. T. Tiekink and P. J. Scammells, Bioorg. Med. Chem. Lett., 2001, 11, 443 [Links]. | |
| 185 | S. Makleit and V. Dubina, ACH-Models Chem., 2000, 17, 447 | |
| 186 | M. P. Wentland, W. Duan, D. J. Cohen and J. M. Bidlack, J. Med. Chem., 2000, 43, 3558 [Links]. | |
| 187 | G. A. Cain and S. Drummond, Synth. Commun., 2000, 30, 4513 [Links]. | |
| 188 | G. A. Cain and S. Drummond, PCT Int. Appl., WO 00 56735 (Chem. Abstr., 2000, 133, 28164) | |
| 189 | I. Derrick, C. L. Neilan, J. Andes, S. M. Husbands, J. H. Woods, J. R. Traynor and J. W. Lewis, J. Med. Chem., 2000, 43, 48 [Links]. | |
| 190 | D. Lopez, E. Quinoa and R. Riguera, J. Org. Chem., 2000, 65, 4671 [Links]. | |
| 191 | A. Coop, S. M. Al-Mousawi, S. M. Husbands and J. W. Lewis, Tetrahedron Lett., 2000, 41, 7571 [Links]. | |
| 192 | F. Scheinmann, A. V. Stachulski, J. Ferguson and J. L. Law, PCT Int. Appl. WO 00 78,764 (Chem. Abstr., 2001, 134, 56828) | |
| 193 | W. H. Harclerode, R. Gault and M. D. Sandison, PCT Int. Appl. WO 01 34,608 (Chem. Abstr., 2001, 134, 367079) | |
| 194 | F. T. Chiu and Y. S. Lo, US Pat., US 6,177,567 (Chem. Abstr., 2001, 134, 116109) | |
| 195 | S. Garadnay and S. Makleit, ACH-Models Chem., 2000, 137, 258 | |
| 196 | L. H. Feng, L. Jing, C. Y. Wu, M. Y. Hu and M. Yang, Zhongguo
Yiyao Gongye Zazhi, 2000, 31, 437 | |
| 197 | B. Le Bourdonnec, R. E1 Kouhen, M. M. Lunzer, P. Y. Law, H. H. Loh and P. S. Portoghese, J. Med. Chem., 2000, 43, 2489 [Links]. | |
| 198 | S. E. Clarke, G. Dondio, L. F. Raveglia and S. Ronzoni, PCT Int. Appl. WO 00 63,210 (Chem. Abstr., 2000, 133, 32035) | |
| 199 | A. R. Jales, S. M. Husbands and J. W. Lewis, Bioorg. Med. Chem. Lett., 2000, 10, 2259 [Links]. | |
| 200 | A. Coop, A. E. Jacobson, M. D. Aceto, L. S. Harris, J. R. Traynor, J. H. Woods and K. C. Rice, Bioorg. Med. Chem. Lett., 2000, 10, 2449 [Links]. | |
| 201 | S. Ananthan, PCT Int. Appl. WO 01 12,197 (Chem. Abstr., 2001, 134, 178714) | |
| 202 | S. Ananthan, PCT Int. Appl. WO 01 12,196. (Chem. Abstr., 2001, 134, 178713) | |
| 203 | T. Tanaka, H. Nagase, T. Endoh, K. Kawamura, M. Fujimura and T. Komagata, PCT Int. Appl. WO 01 05,794 (Chem, Abstr., 2001, 134, 116111) | |
| 204 | G. F. Sigler and R. Rouhani, PCT Int. Appl. WO 00 78,763 (Chem. Abstr., 2001, 134, 56827) | |
| 205 | J. Schutz, R. Krassnig, H. Schmidhammer, K. Wurst, L. Lattanzi and L. Negri, Heterocycles, 2001, 54, 989 | |
| 206 | A. Coop, C. L. Norton, I. Berzetei-Gurske, J. Burnside, L. Toll, S. M. Husbands and J. W. Lewis, J. Med. Chem., 2000, 43, 1852 [Links]. | |
| 207 | A. Coop, I. Berzetei-Gurske, J. Burnside, L. Toll, J. R. Traynor, S. M. Husbands and J. W. Lewis, Helv. Chim. Acta, 2000, 83, 687 [Links]. | |
| 208 | D. C. Broom, L. Guo, A. Coop, S. M. Husbands, J. W. Lewis, J. H. Woods and J. R. Traynor, J. Pharmacol. Exp. Ther., 2000, 294, 1195 | |
| 209 | I. Derrick, S. M. Husbands, J. Broadbear, J. R. Traynor, J. H. Woods and J. W. Lewis, Helv. Chim. Acta, 2000, 83, 3122 [Links]. | |
| 210 | H. Nagase, T. Miyamoto, K. Kawamura, T. Endoh and H. Sekiyama, PCT Int. Appl. WO 01 14,382 (Chem. Abtsr., 2001, 134, 193606) | |
| 211 | W. Fleischhacker and B. Richter, Monatsh. Chem., 2000, 131, 997 [Links]. | |
| 212 | J. D. White and P. Hrnciar, J. Org. Chem., 2000, 65, 2646 [Links]. | |
| 213 | D. A. Frey, C. Duan, I. Ghivriga and T. Hudlicki, Collect. Czech. Chem. Commun., 2000, 65, 561 [Links]. | |
| 214 | J. Mulzer, J. W. Bats, S. Porth, T. Opatz and D. Trauner, Proc. ECSOC-1, First Int. Electron. Conf. Synth. Org. Chem.; Proc. ECSOC-2, Second Int. Electron. Conf. Synth. Org. Chem., 1997, 1998, 1999, 498, (Chem. Abstr., 2001, 134, 207990) | |
| 215 | B. H. Noval, T. Hudlicky, J. W. Reed, J. Mulzer and D. Trauner, Curr. Org. Chem., 2000, 4, 343 | |
| 216 | T. Hudlicky, J. Heterocycl. Chem., 2000, 37, 535 | |
| 217 | T. Warncke, A. Stubhaug and E. Jorum, Pain, 2000, 86, 293 [Links]. | |
| 218 | W. Stoiber, A. M. Sanger and F. Lembeck, Arzneim.-Forsch., 2000, 50, 683 | |
| 219 | K. Eckhardt, S. Ammon, U. Hofmann, A. Reibe, N. Gugelar and G. Mikus, Anesth. Analg. (Baltimore), 2000, 91, 185 | |
| 220 | D. Fletcher, M. Gentili, J.-X. Mazoit and K. Samii, Fundam. Clin. Pharmacol., 2000, 14, 327 [Links]. | |
| 221 | Y. Pang, X. C. Li, H. D. Li, Y. Q. Xu, Y. Xiong and F. Y. Gong, Di-San Junyi Daxue Xuebao, 2000, 22, 720 | |
| 222 | M. R. Zarrindast, S. Shaverdhan and M. Sahebgharani, Pharmacol. Toxicol. (Copenhaqen), 2000, 87, 131 | |
| 223 | R. J. Marcus, B. A. Victoria, R. C. Rushman and J. P. Thompson, Br. J. Anaesth., 2000, 84, 739 | |
| 224 | J. Frackenpohl, Chem. Unserer Zeit, 2000, 4, 99 | |
| 225 | I. V. Belozertseva, O. A. Dravolina, O. N. Neznanova, W. Danysz and A. Y. Bespalov, Eur. J. Pharmacol., 2000, 396, 77 [Links]. | |
| 226 | J. J. Rady, B. B. Holmes, P. S. Portoghese and J. M. Fujimoto, Proc. Soc. Exp. Biol. Med., 2000, 224, 93 | |
| 227 | M. A. Coudore-Civiale, C. Courteix, M. Boucher, M. Meen, J. Filiap A. Eschalier and D. Ardid, Neurosci. Lett., 2000, 286, 37 [Links]. | |
| 228 | M. Mas, A. Sabater, M. J. Olaso, J. F. Horga and C. C. Foura, Brain Res., 2000, 866, 109 [Links]. | |
| 229 | S. Kishioka, M. C. Ko and J. H. Woods, Eur. J. Pharmacol., 2000, 397, 85 [Links]. | |
| 230 | I. A. Hendry, K. L. Kelleher, S. E. Bartlett, K. J. Leck, A. J. Reynolds, K. Heydon, A. Mellick, D. Megirian and K. I. Matthaei, Brain Res., 2000, 870, 10 [Links]. | |
| 231 | V. S. Grover, A. Sharma and M. Singh, Eur. J. Pharmacol., 2000, 399, 161 [Links]. | |
| 232 | M. Inoue and H. Ueda, J. Pharmacol. Exp. Ther., 2000, 29, 662 | |
| 233 | R. B. Karanek and B. Homoleski, Pharmacol. Biochem. Behav., 2000, 66, 653 [Links]. | |
| 234 | V. Granados-Soto, I. Kalcheva, X. Y. Hua, A. Newton and T. L. Yaksh, Pain, 2000, 85, 395 [Links]. | |
| 235 | S. E. Harte, A. I. Lagman and G. S. Borszcy, Brain Res., 2000, 874, 78 [Links]. | |
| 236 | C. J. La Buda and P. N. Fuchs, Neurosci. Lett., 2000, 290, 137 [Links]. | |
| 237 | J. Zong and G. M. Pollack, Pharm. Res., 2000, 17, 653 | |
| 238 | C. S. Wong, M. M. Hsu, R. Chou, Y. Y. Chou and C. S. Tung, Br. J. Anaesth., 2000, 85, 747 | |
| 239 | D. H. Beck, M. Schenk, U. Doepfmer and W. J. Kox, Br. J. Anaesth., 2000, 85, 658 | |
| 240 | A. Miriam, D. Ramirez, G. P. H. Delgadillo, R. V. Martinez, M. I. D. Reval and F. J. Lopez-Munoz, Drug Dev. Res., 2000, 51, 260 [Links]. | |
| 241 | B. Kest and E. Hopkins, Brain Res., 2000, 892, 208 [Links]. | |
| 242 | A. M. Lynn, M. K. Nespeca, S. L. Bratton and D. D. Shen, Pain, 2000, 88, 89 [Links]. | |
| 243 | M. A. Coudore-Civiale, C. Couteix, J. Fialip, M. Boucher and A. Eschalier, Pain, 2000, 88, 15 [Links]. | |
| 244 | X. Huang, J. S. Tang, B. Yuan and H. Jia, Neurosci. Lett., 2001, 299, 189 [Links]. | |
| 245 | W. Pakulska and E. Czarnecka, Pharmazie, 2001, 56, 89 | |
| 246 | S. V. Litvinova, V. V. Aristova, V. V. Shulgovskii, N. N. Terebilina and L. F. Panchenko, Bull. Exp. Biol. Med., 2000, 129, 474 [Links]. | |
| 247 | M. K. Erjavec, B. A. Coda, Q. Nguyen, G. Donaldson, L. Risler and D. D. Shen, J. Clin. Pharmacol., 2000, 40, 1286 | |
| 248 | C. Liu, S. Cai, Y. Peng, M. Zhang and M. Huang, Huaxi Yike Daxue Xuebao, 2000, 31, 350 | |
| 249 | I. Okulicz-Kozaryn, E. Kaminska, J. Luczak, K Szczawinska, A. Kotlinska-Lemieszek, E. Baczyk and P. Mikolajczak, J. Basic Clin. Physiol. Pharmacol., 2000, 11, 109 | |
| 250 | M. Abdollahi and S. Nifkarand L. Habibi, Pharmacol. Res., 2000, 43, 255 [Links]. | |
| 251 | T. M. Hemmerling, W. M. Budde, W. Koppert and J. B. Joans, Anesth. Analg. (Baltimore), 2000, 91, 585 | |
| 252 | L. M. Bohn, R. R. Gainetdinov, F. T. Lin, R. J. Lefkowitz and M. G. Caron, Nature, 2000, 408, 720 [Links]. | |
| 253 | T. Nishiyama and K. Hanaoka, Anesth. Analg. (Baltimore), 2000, 91, 652 | |
| 254 | F. Khalfi, Eur. J. Anaesthesiol., 2000, 17, 459 [Links]. | |
| 255 | M. Silvasti, N. Svartling, M. Pitkanen and P. H. Rosenberg, Eur. J. Anaesthesiol., 2000, 17, 448 [Links]. | |
| 256 | T. Niemann, L. G. Madsen, S. Larsen and N. Thorsgaard, Int. J. Pancreatol., 2000, 27, 235 | |
| 257 | B. Guignard, A. E. Bossard, C. Coste, D. I. Sessler, C. Lebrault, P. Alfonsi, D. Fletcher and M. Chauvin, Anesthesiology, 2000, 93, 409 | |
| 258 | K. J. Powell, W. Ma, M. Sutak, H. Doods, R. Quirion and K. Jhamandas, Br. J. Pharmacol., 2000, 131, 875 | |
| 259 | R. B. Su, J. Li, K. Gao, G. Pei and B. Y. Qin, Acta Pharmacol. Sin., 200, 21, 1011 | |
| 260 | A. A. Larson, K. J. Kovacs and A. K. Spartz, Eur. J. Pharmacol., 2000, 407, 267 [Links]. | |
| 261 | P. J. Cole, D. A. Craske and R. G. Wheatley, Br. J. Anaesth., 2000, 85, 233 | |
| 262 | J. Lilleso, N. A. Hammer, J. L. Pedersen and H. Kehlet, Br. J. Anaesth., 2000, 85, 228 | |
| 263 | A. Rizzi, R. Bigoni, G. Marzola, R. Guerrini, S. Salvadori, D. Regoli and G. Calo, NeuroReport, 2000, 11, 2369 | |
| 264 | D. Pitschas, J. Jageand and C. Henrich-Erble, Acute Pain, 2000, 3, 70 | |
| 265 | P. Klepstad, S. kaasa, M. Skauge and P. C. Borchgrevink, Acta Anaesthesiol. Scand., 2000, 44, 656 | |
| 266 | S. S. Rueben and J. P. Reuben, Anesth. Analg. (Baltimore), 2000, 91, 379 | |
| 267 | X. Xu, C. Guo, W. Jia, Z. Shao and X. Wang, Zhongguo Zhongliu Linchang, 2000, 27, 279 | |
| 268 | T. Nishiyama, R. J. Y. Ho, D. D. Shen and T. L. Yaksh, Anesth. Analg. (Baltimore), 2000, 91, 423 | |
| 269 | E. Zarate, P. Latham, P. F. White, R. Bossard, L. Morse, L. K. Douning C. Shi and L. Chi, Anesth. Analg. (Baltimore), 2000, 91, 283 | |
| 270 | C. D. Cook, A. C. Barrett, C. Syvanthong and M. J. Picker, Psychopharmacology (Berlin), 2000, 152, 93 | |
| 271 | B. Kest, C. Palmese and E. Hopkins, Brain Res., 2000, 879, 17 [Links]. | |
| 272 | H. Berkenstadt, H. Mayan, E. Segal, M. Rotenberg, S. Almog, A. Perel and D. Ezra, J. Clin. Anesth., 1999, 11, 630, (Chem. Abstr., 2000, 133, 37670) [Links]. | |
| 273 | D. Huttova, M. Gajdos, K. Gazdikova, M. Zemanek, S. Somorovsky and R. Dzurik, Farm. Obz., 2001, 70, 68 | |
| 274 | J. Drewe, H. A. Ball, C. Beglinger, B. Peng, A. Kemmlert, H. Schachinger and W. E. Haefeli, Br. J. Clin. Pharmacol., 2000, 50, 237 [Links]. | |
| 275 | M. Dershwitz, J. L. Walsh, R. J. Morishige, P. M. Connors, R. M. Rubsamen, S. L. Shafer and C. E. Rosow, Anesthesiology, 2000, 93, 619 | |
| 276 | M. R. Bouw, M. Gardmark and M. Hammarlund-Udenaes, Pharm. Res., 2000, 17, 1220 [Links]. | |
| 277 | F. Moolenaar, W. J. Meijler, H. W. Frijlink, J. Visser and J. H. Proost, Eur. J. Clin. Pharmacol., 2000, 56, 219 [Links]. | |
| 278 | K. Eckhardt, I. Nevo, R. Levy, G. Mikus, M. Eichelbaum and Z. Vogel, FEBS Lett., 2000, 470, 309 [Links]. | |
| 279 | M. M. Doherty and K. S. Pang, Pharm. Res., 2000, 17, 291 [Links]. | |
| 280 | C. King, B. Finley and R. Franklin, Drug Metab. Dispos., 2000, 28, 661 | |
| 281 | E. Nagano, H. Yamada and K. Oguri, Life Sci., 2000, 67, 2453 [Links]. | |
| 282 | W. A. Carlezon, T. A. Kosten and E. J. Nestler, Psychopharmacology (Berlin), 2000, 151, 261 | |
| 283 | A. Badiani, M. M. Oates and T. E. Robinson, Psychopharmacology (Berlin), 2000, 151, 273 | |
| 284 | C. L. Van den Berg, J. M. Van Ree and B. M. Spruijt, Neuropharmacology, 2000, 39, 969 [Links]. | |
| 285 | M. Rodriguez-Arias, I. Brosela, M. A. Aguilar and J. Minarro, Pharmacol. Biochem. Behav., 2000, 66, 189 [Links]. | |
| 286 | T. M. Tzschentke and W. J. Schmidt, Psychopharmacology (Berlin), 2000, 149, 225 | |
| 287 | T. Suzuki, H. Kato, T. Aoki, M. Tsuda, M. Narita and M. Misawa, Life Sci., 2000, 67, 383 [Links]. | |
| 288 | A. Poling, T. Byrne, L. Christian and M. G. Lesage, Pharmacol. Biochem. Behav., 2000, 66, 313 [Links]. | |
| 289 | B. E. Schroeder, M. R. Holahan, C. F. Landry and A. E. Kelley, Synapse (N.Y.), 2000, 37, 146 | |
| 290 | M. R. Brandt, R. Galici and C. P. France, Behav, Pharmacol., 2000, 11, 15 | |
| 291 | Y. H. Ren and J. W. Zeng, Acta Pharmacol. Sin., 2000, 21, 924 | |
| 292 | C. Liu, S. Cai, Y. Peng, M. Zhang and M. Huang, Huaxi Yike Daxue Xuebao, 200, 31, 350 | |
| 293 | M. Kalinichev, K. E. Easterling and S. G. Holtzman, Psychopharmacology (Berlin), 2000, 152, 431 | |
| 294 | M. Narita, T. Aoki and T. Suzuki, Neuroscience (Oxford), 2000, 101, 601 | |
| 295 | M. Narita, T. Aoki and T. Suzuki, Nippon
Yakurigaku Zazhi, 2001, 117, 13 | |
| 296 | P. Sacerdote, M. Bianchi, L. Gaspani, B. Manfredi, A. Maucione, G. Terno, M. Ammatuna and A. E. Panerai, Anesth. Analg. (Baltimore), 2000, 90, 1411 | |
| 297 | I. Vathy, H. J. He, M. Iodice, O. C. Hnatczuk and A. Rimanoczy, Brain Res. Bull., 2000, 51, 267 [Links]. | |
| 298 | S. Singh and P. P. Singh, Life Sci., 2000, 67, 1035 [Links]. | |
| 299 | Y. C. Tsai, S. J. Won and M. T. Lin, Pain, 2000, 88, 155 [Links]. | |
| 300 | I. D. Welters, A. Menzebach, Y. Gaumon, T. W. Langefeld, H. Teschemacher, G. Hempleman and G. B. Stefano, J. Neuroimmunol., 2000, 111, 139 [Links]. | |
| 301 | Q. Li, Y. P. Li, Z. Q. Yan and X. C. Qiu, Zhongguo Bingli Shengli Zazhi, 2000, 16, 354 | |
| 302 | L. Velisek, P. K. Stanto, S. L. Moshe and I. Vathy, Brain Res., 2000, 869, 186 [Links]. | |
| 303 | L. H. Mildh, L. M. Tuomisto, M. Scheinin and O. A. Kirvela, Anesth. Analg. (Baltimore), 2000, 91, 51 | |
| 304 | P. Burduk, P. Guzik, M. Piechocka, M. Bronisz, A. Rozek, M. Jazdon and M. R. Jordan, Cardiovasc. Drugs Ther., 2000, 14, 259 [Links]. | |
| 305 | C. S. Patil and S. K. Kulkarni, Indian J. Pharmacol., 2000, 32, 321 | |
| 306 | Y. Ise, S. Katayama, M. Hirano, T. Aoki, M. Narita and T. Suzuki, Neurosci. Lett., 2001, 299, 29 [Links]. | |
| 307 | T. Hirayama, F. Ishii, K. Yago and H. Ogata, Yakugaku Zasshi, 2001, 121, 179 | |
| 308 | A. Veeranjeaneyulu, N. Sridhar, R. J. Babu, C. N. V. H. B. Gupta, R. Malavika and S. K. S. Shobana, Pharm. Pharmacol. Commun., 2000, 6, 513 | |
| 309 | R. S. Karan, R. Kumar and P. Pandhi, Indian J. Physiol. Pharmacol., 2000, 43, 345 | |
| 310 | A. I. Vislobokov, Eksp. Klin. Farmakol., 2000, 63, 7 | |
| 311 | M. H. Saiepour, S. Semnanian and Y. Fathollahi, Eur. J. Pharmacol., 2001, 411, 85 [Links]. | |
| 312 | X. Chen, H. G. Marrero, R. Murphy, Y. J. Lin and J. Freedman, Proc. Natl. Acad. Sci. U. S. A., 2000, 97, 14692 [Links]. | |
| 313 | J. L. Cao, Y. M. Zeng, L. C. Zhang and S. M. Duan, Shengli Xuebao, 2000, 52, 235 | |
| 314 | S. Haq, S. Shaharyar and A. Siddiqui, J. Chem. Soc. Pak., 1999, 21, 295, (Chem. Abstr., 2001, 134, 141678) | |
| 315 | S. L. Jinks and E. Carstens, J. Neurophysiol., 2000, 84, 616 | |
| 316 | K. S. Eriksson, D. R. Stevens and H. L. Haas, Neuropharmacology, 2000, 39, 2492 [Links]. | |
| 317 | X. Nie, Z. Y. Wen, Z. Y. Yan, L. Huang, D. Sun and B. Cheng, Clin. Hemorheol. Microcirc., 2000, 22, 189 | |
| 318 | X. Ni, K. R. Gritman, T. K. Eisenstein, M. W. Adler, K. E. Arfors and R. F. Tuma, Microvasc. Res., 2000, 60, 121 [Links]. | |
| 319 | S. Suzuki, T. Miyagi, T. K. Chuang, L. F. Chuang, R. H. Doi and R. Y. Chuang, Biochem. Biophys. Res. Commun., 2000, 279, 621 [Links]. | |
| 320 | I. D. Welters, A. Menzebach, Y. Gouman, P. Cardet, T. Menges and T. K. Hughes, Anesthesiology, 2000, 92, 1677 | |
| 321 | A. Ulugol, T. Dost, D. Domeci, M. Akpolat, C. H. Karadag and I. Domeci, J. Neural Transm., 2000, 107, 515 [Links]. | |
| 322 | B. Kest, M. Adler and E. Hopkins, Neurosci. Lett., 2000, 291, 126 [Links]. | |
| 323 | M. W. Quinn and A. Vokes, Early Human Dev., 2000, 59, 27 [Links]. | |
| 324 | T. A. Costen and J. C. Bombace, Brain Res., 2000, 878, 20 [Links]. | |
| 325 | M. Tsuji, H. Takeda, T. Matsumiya, H. Nagase, M. Narita and T. Suzuki, Life Sci., 2001, 68, 1717 [Links]. | |
| 326 | R. M. Silva, G. C. Rossi, J. P. Mathis, K. M. Staudifer, G. W. Pasternak and R. J. Bodnor, Brain Res., 2000, 876, 62 [Links]. | |
| 327 | C. Abarca, E. Silva, M. J. Sepulveda and P. Oliva, Eur. J. Pharmacol., 2000, 403, 67 [Links]. | |
| 328 | Y. S. Zeng, J. L. Wu, S. J. Chen and H. J. Zhang, Jiepou Xuebao, 2000, 31, 302 | |
| 329 | D. A. Bereiter and D. F. Bereiter, Pain, 2000, 85, 65 [Links]. | |
| 330 | S. E. Zebraski, S. M. Kochenash and R. B. Raffa, Life Sci., 2000, 66, 2221 [Links]. | |
| 331 | E. A. Kopecky, M. L. Ryan, J. F. R. Barrett, P. G. R. Seaward, G. Ryan, G. Koren and K. Aamankwah, Am. J. Obstet. Gynecol., 2000, 183, 424 [Links]. | |
| 332 | E. Saarenmaa, P. J. Neuvonen, P. Rosenberg and V. Fellman, Clin. Pharmacol. Ther., 2000, 68, 160 [Links]. | |
| 333 | M. A. Kraus and C. Kornetsky, Brain Res., 2000, 865, 194 [Links]. | |
| 334 | F. Gomez, N. A. Leo and P. S. Grigson, Brain Res., 2000, 863, 52 [Links]. | |
| 335 | H. M. Yeh, L. K. Chen, C. J. Lin, W.
H. Chan, Y. P. Chen, C. S. Lin, W. Z. Sun, M. J. Wang and S. K. Tsai, Anesth. Analg. (Baltimore), 2000, 91, 172 | |
| 336 | S. Charuluxananan, S. Somboonviboon, O. Koyokong and K. Nimcharoendee, Req. Anesth. Pain Med., 2000, 25, 535 | |
| 337 | E. Kolaczowska, E. Menaszek, R. Seljelid and B. Plytycz, Pol. J. Pharmacol., 2000, 52, 323 | |
| 338 | M. C. Barr, J. N. Billaud, D. R. Selway, S. Huitron-Resendiz, K. G. Osborn, S. J. Henriksen and T. R. Phillips, J. Infect. Dis., 2000, 182, 725 [Links]. | |
| 339 | K. Kanaya, P. A. Murray, D. S. Damron, M. Nakayama, M. Yamakage and A. Namiki, Prog. Anesth. Mech., 2000, 6, 408 | |
| 340 | P. C. Singhal, A. A. Kapasi, N. Franki and K. Reddy, Immunology, 2000, 100, 57 [Links]. | |
| 341 | J. C. Yang, J. Shan, F. Ng and P. Pang, Brain Res., 2000, 870, 199 [Links]. | |
| 342 | S. Karunanithi and N. A. Lavidis, Br. J. Pharmacol., 2001, 132, 403 | |
| 343 | M. I. Lioudyno, M. Verbitsky, J. C. Holt, A. B. Elgoyhen and P. S. Guth, Hear. Res., 2000, 149, 167 [Links]. | |
| 344 | S. Oh, Korean J. Physiol. Pharmacol., 2000, 4, 291 | |
| 345 | W. Zhou, X. Xie, H. Liu and G. Wang, Zhongguo Yaolixue Xuebao, 2000, 16, 99 | |
| 346 | V. Zachariou, J. Thome, K. Parikh and M. R. Picciotto, Neuropsychopharmacology, 2000, 2, 127 [Links]. | |
| 347 | A. A. Kapasi, N. Gibbons, J. Mattana and P. C. Singhal, Inflammation (N.Y), 2000, 24, 463 | |
| 348 | C. S. Wong, M. M. Hsu, Y. Y. Chou, P. L. Tao and C. S. Tung, Br. J. Anaesth., 2000, 85, 587 | |
| 349 | F. He, Y. An, H. Yin, C. Wei and J. Li, Henan Yike Daxue Xuebao, 2000, 35, 422 | |
| 350 | T. Miyagi, L. F. Chuang, R. H. Doi, M. P. Carlos and J. V. Torres, J. Biol. Chem., 2000, 275, 31305 [Links]. | |
| 351 | S. Kaewsuk P. Hutamekalin, A. J. Ketterman, N. Khotchabakdi, P. Govitrapong and S. O. Casalotti, Eur. J. Pharmacol., 2001, 411, 11 [Links]. | |
| 352 | A. S. MacFarlane, X. Peng, J. J. Miessler, T. J. Rogers, E. B. Geller, M. W. Adler and T. K. Eisenstein, J. Infect. Dis., 2000, 181, 1350 [Links]. | |
| 353 | J. A. V. Mikkola, A. Honkanen, T. P. Piepponen, K. Kiianmaa and L. Ahtee, Pharmacol. Biochem. Behav., 2000, 67, 783 [Links]. | |
| 354 | E. J. Van Bockstaele, J. Peoples, A. S. Menko, K. McHugh and G. Drolet, J. Neurosci., 2000, 20, 8659 | |
| 355 | W. Ma and W. H. Zengand R. Quirion, Neuroscience (Oxford), 2000, 99, 529 | |
| 356 | B. Zubelewicz, M. Muc-Wierzgon and M. S. Harbuz, Endokrynol. Pol., 2000, 51, 57 | |
| 357 | X. Peng, D. M. Mosser, M. W. Adler, T. J. Rogers, J. J. Meissler and T.
K. Eisenstein, J. Leukocyte Biol., 2000, 68, 723 | |
| 358 | J. H. Li, Z. D. You, Z. Y. Chen, C. Y. Song and C. L. Lu, Neurosci. Lett., 2001, 300, 58 [Links]. | |
| 359 | Z. D. You, J. H. Li, C. Y. Song, C. H. Wang and C. L. Lu, NeuroReport, 2000, 11, 3113 | |
| 360 | C. G. Jang, Y. Park, S. Tanaka, T. Ma, H. H. Loh and I. K. Ho, Mol. Brain Res., 2000, 78, 204 [Links]. | |
| 361 | S. Atamer-Simsek, H. Olmez-Salvarli, O. Guc and L. Eroglu, Pharmacol. Res., 2000, 41, 55 [Links]. | |
| 362 | M. Khalili, S. Semnania and Y. Fathollahi, Eur. J. Pharmacol., 2001, 412, 239 [Links]. | |
| 363 | M. Erdtmann-Vourliotis, P. Mayer, U. Reichert and V. Hollt, Mol. Brain Res., 2000, 77, 55 [Links]. | |
| 364 | E. A. Blokhina, I. A. Sukhotina and A. Y. Bespalov, Eur. J. Pharmacol., 2000, 406, 227 [Links]. | |
| 365 | L. Langerman, R. A. Steingart, A. Margolis and J. Yani, J. Pharmacol. Toxicol. Methods, 2000, 42, 115 [Links]. | |
| 366 | C. M. Felip, M. Rodriguez-Arias, E. F. Espejo, J. Minarro and L. Stinus, Behav. Neurosci., 2000, 114, 424 [Links]. | |
| 367 | P. Cegar and C. M. Kuhn, Psychopharmacology (Berlin), 2000, 150, 253 | |
| 368 | M. Samini, R. Fakhrian, M. Mohagheghi and A. R. Dehpour, Hum. Psychopharmacol., 2000, 15, 95 | |
| 369 | A. R. Dehpour, M. Samini, H. Rastegar, A.
J. Ardeshiri, F. Roushanzamir, M. Jorjani and A. Ahmadiani, Hum. Psychopharmacol., 2000, 15, 213 | |
| 370 | S. V. Litvinova, V. V. Shulgovsky, M. A. Grunden, L. F. Pancehnko, N. N. Terebilina, V. V. Aristova and A. L. Kalyuzhny, Patol. Fiziol. Eksp. Ter., 2000, 6 | |
| 371 | X. Lu, G. Bing and T. Hagg, Neuroscience (Oxford), 2000, 97, 285 | |
| 372 | A. I. Svenson, A. Berntsson, M. Eirfelt and B. Soderpalm, J. Neural Transm., 2000, 107, 261 | |
| 373 | B. Liu, L. Du, L. Y. Kong, P. M. Hudson, B. C. Wilson, R. C. Chang, H. H. Abel and J. S. Hong, Neuroscience (Oxford), 2000, 97, 749 | |
| 374 | B. Liu, L. Du and J. S. Hong, J. Pharmacol. Exp. Ther., 2000, 293, 607 | |
| 375 | B. Liu, J. W. Jiang, B. C. Wilson, L. Du, S. N. Yang, J. Y. Wong, G. C. Wu, X. D. Cao and J. S. Hong, J. Pharmacol. Exp. Ther., 2000, 295, 125 | |
| 376 | W. Kong, B. Xu, W. Feng, S. Huang, S. Qi, W. Ren and X. Li, Zhongguo Shenjing Jingshen Jibing Zazhi, 2000, 26, 87 | |
| 377 | R. Zamani, S. Semnania, Y. Fathollahi and S. Hajizadeh, Eur. J. Pharmacol., 2000, 408, 299 [Links]. | |
| 378 | M. Zubrzycka and A. Janecka, Regul. Pept., 2001, 97, 7 [Links]. | |
| 379 | M. Zubrzycka and A. Janecka, J. Physiol. Pharmacol., 2000, 51, 471 | |
| 380 | L. C. Newman, D. R. Wallace and C. W. Stevens, Brain Res., 2000, 884, 184 [Links]. | |
| 381 | S. L. Cruz and G. Rodriguez-Manzo, Eur. J. Pharmacol., 2000, 397, 121 [Links]. | |
| 382 | C. J. Cheng, F. C. Cheng, S. L. Liao, W. Y. Chen, N. N. Lin and J. S. Kuo, Neurosci. Lett., 2000, 287, 113 [Links]. | |
| 383 | D. Mangold, M. E. McCaul, M. Ali and G. S. Wand, Biol. Psychiatry, 2000, 48, 310 [Links]. | |
| 384 | S. Tokuyama, I. K. Ho and T. Yamamoto, Brain Res. Bull., 2000, 52, 363 [Links]. | |
| 385 | L. Amass, J. B. Kamien and S. K. Mikulich, Drug Alc. Depend., 2000, 58, 143 | |
| 386 | C. Belzung, S. Barreau and A. Agno, Eur. J. Pharmacol., 2000, 394, 289 [Links]. | |
| 387 | H. Xu, S. J. Li, J. Bodurka, X. Zhao, X. Zheng and S. A. Stein, NeuroReport, 2000, 11, 1085 | |
| 388 | P. Grigson, R. C. Twining and R. M. Carelli, Pharmacol. Biochem. Behav., 2000, 66, 603 [Links]. | |
| 389 | J. Yanai, R. A. Steingart, N. Snapir, G. Ggvaryahu, I. Rosenboim and A. Katz, Ann. N. Y. Acad. Sci., 2000, 914, 402 | |
| 390 | H. L. Alderson, J. A. Parkinson, T. W. Robbins and B. J. Everitt, Psychopharmacology (Berlin), 2001, 153, 455 | |
| 391 | J. Zhou, P. Si, Z. Ruan. S. Ma, X. Yan, L. Sun, F. Peng, H. Yuan, D. Cai, D. Ding and S. Xu, Chin. Med. J., 2001, 114, 297 | |
| 392 | D. M. Hutcheson, J. A. Parkinson, T. W. Robbins and B. J. Everitt, Psychopharmacology (Berlin), 2001, 153, 464 | |
| 393 | H. L. Alderson, T. W. Robbins and B. J. Everitt, Psychopharmacology (Berlin), 2001, 153, 120 | |
| 394 | H. L. Alderson, T. W. Robbins and B. J. Everitt, Psychopharmacology (Berlin), 2001, 153, 111 | |
| 395 | J. Zhang, Y. Zhang and H. Shao, Zhongguo Yaowu Yilaixing Zazhi, 2000, 9, 194 | |
| 396 | A. Yang, J. Wang, D. Liu and J. Wei, Zhongguo Yaowu Yilaixing Zazhi, 2000, 9, 192 | |
| 397 | J. Zhang, Z. Yang, G. Liu, G. Chen, S. Li, W. Ci, J. Qiao, Y. Lin, S. Pei and C. Li, Zhongguo Mianyixue Zazhi, 2000, 16, 361 | |
| 398 | Z. X. Xi and E. A. Stein, J. Pharmacol. Exp. Ther., 2000, 294, 613 | |
| 399 | Y. Shaham, S. Erb and J. Syewart, Brain Res. Rev., 2000, 33, 13 [Links]. | |
| 400 | T. R. A. Macedo, J. Relvas, C. A. F. Ribeiro, F. Pacheco, M. T. Morgadinho, C. M. Pinto, P. C. Gomes, M. Ventura, V. Henriques, S. V. Nunes, G. R. Ruis, C. Ramalheira, I. Boto and L. L. Vale, Ann. N. Y. Acad. Sci., 2000, 914, 303 | |
| 401 | L. F. Panchenko, S. V. Pirozkhov, A. V. Nadezhdin, V. Y. Baronetz and N. N. Usmanova, Vopr. Med. Khim., 1999, 45, 501, (Chem. Abstr., 2001, 134, 95428) | |
| 402 | E. C. Tan, B. K. L. Yeo, B. K. W. Ho, A. H. N. Tan and C. H. Tan, Mol. Psychiatry, 1999, 4, 215, (Chem. Abstr., 2001, 134, 80734) [Links]. | |
| 403 | S. J. Kish, K. S. Kalasinsky, Y. Furukawa, M. Guttman, L. Ang, L. Li, V. Adams, G. Reiber, R. A. Anthony, W. Anderson, J. Smialek and L. DiStefano, Mol. Psychiatry, 1999, 4, 26, (Chem. Abstr., 2001, 134, 25280) [Links]. | |
| 404 | P. Franke, M. M. Nothen, T. Wang, M. Knapp, D. Lichtermann, H. Neidt, T. Sander, P. Propping and W. Maier, Mol. Psychiatry, 2000, 5, 101 [Links]. | |
| 405 | R. Xie, M. R. Bouw and M. Hammarlund-Udenaes, Br. J. Pharmacol., 2000, 131, 1784 | |
| 406 | M. Grung, S. Skurtveit, A. Ripel and J. Morland, Pharmacol. Biochem. Behav., 2000, 66, 205 [Links]. | |
| 407 | P. B. Osborne, B. Chieng and M. J. Christie, Br. J. Pharmacol., 2000, 131, 1422 | |
| 408 | R. S. Sinatra, S. Lewin and C. A. Ocampo, Semin. Anesth. Perioper. Med. Pain, 2000, 19, 108, (
Chem. Abstr., 2000, 133, 275740) | |
| 409 | J. L. Hill and J. P. Zacny, Psychopharmacology (Berlin), 2000, 152, 31 | |
| 410 | T. G. Metzger, M. G. Paterlini, D. M. Ferguson and P. S. Portoghese, J. Med. Chem., 2001, 44, 857 [Links]. | |
| 411 | L. Pan, L. Xie, L. Chen, Y. Ning and S. Lu, Zhongguo Yaowu Yilaixing Zazhi, 2000, 9, 19 | |
| 412 | L. Pan, L. Xie, L. Chen, Y. Ning and S. Lu, Zhongguo Yaowu Yilaixing Zazhi, 2000, 9, 70 | |
| 413 | S. Ammon, O. Von Richter, U. Hofmann, K. P. Thon, M. Eichelbaum and G. Mikus, Drug Metab. Dispos., 2000, 28, 1149 | |
| 414 | M. Farre, P. N. Rosett, J. A. Pascual, M. Mas, J. Sanagustin, E. Menoyo and A. Baena, Dolor, 1999, 14, 279, (Chem. Abstr., 2000, 133, 53105
) | |
| 415 | V. Dahl, F. Fjellanger and J. C. Raeder, Eur. J. Pain (London), 2000, 4, 211 | |
| 416 | D. G. Williams, D. J. Hatch and R. F. Howard, Br. J. Anaesth., 2001, 86, 413 | |
| 417 | M. Palangio, M. J. Damask, E. Morris, R. T. Doyle, J. G. Jiang, C. J. Landau and A. De Padova, Clin. Ther., 2000, 22, 879 [Links]. | |
| 418 | T. B. Vree, R. T. M. Van Dongen and P. M. Koopman-Kimenai, Int. J. Clin. Pract., 2000, 54, 395 | |
| 419 | S. Wachtel and H. de Wit, Drug Alc. Depend., 2000, 59, 251 | |
| 420 | G. Pozzi, G. Conte and S. De Risio, Drug Alc. Depend., 2000, 59, 287 | |
| 421 | L. D. Middaugh and A. L. E. Bandy, Psychopharmacology (Berlin), 2000, 151, 321 | |
| 422 | T. Baptista, A. Lacruz, A. Acosta, C. Colasante, M. de Quijada, S. de Mendoza, J. M. Mendoza and L. Hernandez, Appetite (London), 2000, 34, 77 | |
| 423 | H. Krazler, V. Modesto-Lowe and J. Van Kirk, Neuropsychopharmacology, 2000, 22, 493 [Links]. | |
| 424 | A. C. King and P. J. Meyer, Pharmacol. Biochem. Behav., 2000, 66, 563 [Links]. | |
| 425 | H. Zhu and G. A. Barr, Psychopharmacology (Berlin), 2000, 150, 253 | |
| 426 | S. M. Crain and K. F. Shen, Brain Res., 2001, 888, 75 [Links]. | |
| 427 | B. Lu, G. Xu and R. Zhang, Zhongguo Yaoxue Zazhi, 2000, 35, 524 | |
| 428 | A. V. Azzara, R. J. Bodnar, A. R. Delamater and A. Sclafani, Pharmacol. Biochem. Behav., 2000, 67, 545 [Links]. | |
| 429 | H. Kadokawa and Y. Yamada, Theriogenology, 2000, 54, 75 [Links]. | |
| 430 | L. E. F. Almeida, E. F. R. Pereira, M. Alkondon, W. P. Fawcett, W. R. Randall and E. X. Albuquerque, Neuropharmacology, 2000, 39, 2740 [Links]. | |
| 431 | H. Inoue, Eur. J. Pharmacol., 2000, 406, 375 [Links]. | |
| 432 | C. S. Chun and J. F. Foss, Drug Dev. Res., 2000, 50, 133 [Links]. | |
| 433 | J. P. Mathis, C. D. Mandyam, G. F. Altemeni, G. W. Pasternak and K. M. Standifer, Neurosci. Lett., 2001, 299, 173 [Links]. | |
| 434 | A. V. Kuzmin, M. A. F. M. Gerrits, E. E. Zvartau and J. M. van Ree, Eur. Neuropsychopharmacol., 2000, 19, 447 [Links]. | |
| 435 | R. Fournier, E. Van Gessel, M. Macksay and Z. Gamulin, Acta Anaesthesiol. Scand., 2000, 44, 940 | |
| 436 | X. Culebras, G. Gaggero, J. Zatloukal, C. Kern and R.-E. Marti, Anesth. Analg. (Baltimore), 2000, 91, 601 | |
| 437 | A. Ren and J. Su, Zhongguo Yaowu Yilaixing Zazhi, 2000, 9, 14 | |
| 438 | D. A. Rosen, J. L. Morris, K. R. Rosen, E. Nelson, R. J. Steelman, R. A. Gustafson, J. A. Wilhelm, C. T. Chang, J. W. Thakara and R. F. Frye, Pharmacotherapy, 2000, 20, 745 | |
| 439 | H. E. Jones, R. E. Johnson, P. S. Fudala, J. D. Henningfield and S. J. Heishman, Drug Alc. Depend., 2000, 60, 29 | |
| 440 | W. M. Clarke, E. C. Raps, D. C. Tong and R. E. Kelly, Stroke, 2000, 31, 1234 | |
| 441 | N. K. Mello, J. H. Mendelson and M. Kelly, Pharmacol. Biochem. Behav., 2000, 66, 275 [Links]. | |
| 442 | T. J. Martin, S. A. Kim, D. G. Cannon, G. M. Sizemore, D. Bian, F. Porreca and J. E. Smith, J. Pharmacol. Exp. Ther., 2000, 294, 975 | |
| 443 | R. M. Jones and P. S. Portoghese, Eur. J. Pharmacol., 2000, 396, 49 [Links]. | |
| 444 | B. Le Bourdonnec, R. El Kouhen, G. Poda, P. Y. Law, H. H. Loh, D. M. Ferguson and P. S. Portoghese, J. Med. Chem., 2001, 44, 1017 [Links]. | |
| 445 | M. Garrido, J. Gubbens-Stibbe, E. Tukker, E. Cox, J. Von Frijtag, D. Kunzel, A. Ijzerman, M. Danhof and P. H. Van der Graaf, Pharm. Res., 2000, 17, 653 | |
| 446 | D. L. Larson, R. M. Jones, S. A. Hjorth, T. W. Schwarz and P. S. Portoghese, J. Med. Chem., 2000, 43, 1573 [Links]. | |
| 447 | G. F. Stegman, J. S. Afr. Vet. Assoc., 1999, 70, 164, (Chem. Abstr., 2000, 133, 129770) | |
| 448 | M. Melone, N. C. Brecha, C. Sternini, C. Evans and F. Conti, Neuroscience (Oxford), 2000, 100, 439 | |
| 449 | S. Ohmori, T. Hayashi, M. Kawase, S. Saito and Y. Morimoto, J. Pharmacol. Exp. Ther., 2001, 296, 528 | |
| 450 | L. S. Zhang, Z. N. Yan, D. J. Li, H.
Y. Tian, H. W. Ma, Q. Liu, Y. S. Yang and H. H. Feng, Zhongguo Shouyi Xuebao, 2000, 20, 393 | |
| 451 | M. Carrieri, D. Vlahov, P. Dellamonica, H. Gallais, G. Lepeu, B. Spire and Y. Obadia, Drug Alc. Depend., 2000, 60, 51 | |
| 452 | U. Schneider, W. Paetzgold, T. J. Huber, J. Seifert, B. Wise and H. M. Emrich, Addict. Biol., 2000, 5, 65 | |
| 453 | R. Gomez-Flores and R. J. Weber, Immunopharmacology, 2000, 48, 145 [Links]. | |
| 454 | C. J. Harvey-Clark, K. Gilespie and K. W. Riggs, Lab. Anim., 2000, 34, 86 | |
| 455 | D. Volker, M. Bate, R. Gentle and M. Garg, Lab. Anim., 2000, 34, 423 | |
| 456 | M. Bartoletti, C. Gubellini and M. Gaiardi, Pharmacol. Res., 2000, 42, 269 [Links]. | |
| 457 | J. K. Zubieta, M. K. Greenwald, U. Lombardi, J. H. Woods, M. R. Kilbourn, D. M. Jewett, R. A. Koeppe, C. R. Schuster and C. E. Johanson, Neuropsychopharmacology, 2000, 2, 326 [Links]. | |
| 458 | A. B. Criado, I. A. G. De Segura, F. J. Tendillo and F. Marsico, Lab. Anim., 2000, 4, 252 | |
| 459 | P. Bloms-Funke, C. Gillen, A. J. Schuetler and S. Wendt, Peptides (N. Y.), 2000, 21, 1141 | |
| 460 | M. Stringer, M. K. Makin, J. Miles and J. S. Morley, Neurosci. Lett., 2000, 295, 21 [Links]. | |
| 461 | R. J. Miller and P. B. Tran, Trends Pharmacol. Sci., 2000, 21, 299 [Links]. | |
| 462 | M. Cavazza, M. Zandomeneghi and F. Pietra, Tetrahedron Lett., 2000, 41, 9129 [Links]. | |
| 463 | M. Cavazza, G. Guella and F. Pietra, Tetrahedron, 2000, 56, 1917 [Links]. | |
| 464 | J. C. Lee and J. K. Cha, Tetrahedron, 2000, 56, 10175 [Links]. | |
| 465 | P. D. Davis, J. C. Arnould and F. T. Boyle, PCT Int. Appl. WO 00 40529 (Chem. Abstr., 2000, 133, 89673) | |
| 466 | K. Modschiedler, M. Weller, P. Worl and P. Von Den Driesch, Arch. Dermatol. Res., 200, 292, 32 | |
| 467 | A. Rambaldi and C. Gludd, Liver (Copenhagen), 2000, 20, 262 | |
| 468 | H. He and F. Liu, Tianran Chanwu Yanju Yu, 2000, 12, 87 | |
| 469 | L. J. Lee, J. S. Chen, T. L. Ko and S. M. Wang, J. Cell. Biochem., 2001, 81, 162 [Links]. | |
| 470 | T. E. Druley, W. D. Stein, A. Ruth and I. B. Robinson, Biochemistry, 2001, 40, 4323 [Links]. | |
| 471 | D. Das, P. W. Pemberton, P. C. Burrows, C. Gordon, A. Smith, R. F. T. McMahon and T. W. Warnes, Biochim. Biophys. Acta, 02000, 1502, 351 [Links]. | |
| 472 | A. R. Chaudhuri, P. Seetharamalu, P. M. Schwartz, F. H. Hausheer and R. F. Luduea, J. Mol. Biol., 2000, 303, 679 [Links]. | |
| 473 | M. Grimaitre, A. Etienne, M. Fathi, P. A. Piletta and J. H. Saurat, Dermatology (Basel), 2000, 200, 346 | |
| 474 | S. Mons, F. Veretout, M. F. Carlier, I. Erk, J. Lepault, E. Trudel, C. Salesse, P. Ducray, C. Mioskowski and L. Lebeau, Biochem. Biophys. Acta, 2000, 1468, 381 | |
| 475 | L. Dufourny, D. Leroy and M. Warembourg, Brain Res. Bull., 2000, 52, 435 [Links]. | |
| 476 | M. Blaghen, N. Lahlou, F. Z. Dzairi, A. Moutaouakkil and M. Talbi, Nat. Toxins, 1999, 7, 179, (Chem. Abstr., 2001, 134, 36740) [Links]. | |
| 477 | K. F. Shao, Z. Z. Wu, B. C. Wang, M. Long and S. X. Cai, Colloids Surf., 2000, 19B, 55 | |
| 478 | C. W. Wanjala and R. T. Majinda, J. Nat. Prod., 2000, 63, 871 [Links]. | |
| 479 | S. Hosoi, M. Nagao, Y. Tusuda, K. Isobe, T. Sano and T. Ohta, J. Chem. Soc. Perkin Trans. I, 2000, 1505 [Links]. | |
| 480 | A. Toyao, S. Chikaoka, Y. Takeda, O. Tamura, O. Muraoka, G. Tanabe and H. Ishibashi, Tetrahedron Lett., 2001, 42, 1729 [Links]. | |
| 481 | R. Garcia-Mateos, M. E. Garin Aguilar, M. Soto Hernandez and M. Martinez-Vasquez, Pharm. Pharmacol. Lett., 2000, 10, 34 | |
| 482 | H. Morita, M. Arisaka, N. Yoshida and J. Kobayashi, Tetrahedron, 2000, 56, 2929 [Links]. | |
| 483 | C. P. Zou, K. M. Wu and L. Huang, Chin. Chem. Lett., 2000, 11, 489 | |
| 484 | Q. Zhang and R. Wen, Huaxue Shiji, 2000, 22, 325 | |
| 485 | Z. An, S. Wei, S. Xu and G. Zhao, Huaxi Yike Daxue Xuebao, 2000, 31, 95 | |
| 486 | M. Yang, C. Yang, J. M. S. Bian and Y. Xue, Zhongguo Zhongliu Linchang, 2000, 27, 174 | |
| 487 | A. Montagnac, J.-F. Gallard, M. Litaudon, T. Sevenet and M. Pais, Niger. J. Nat. Prod. Med., 1999, 3, 83, (Chem. Abstr., 2001, 134, 27525) | |
| 488 | W. F. Wood, F. J. Hanke, I. Kubo, J. A. Carroll and P. Crews, Biochem. Syst. Ecol., 2000, 28, 305 [Links]. | |
| 489 | G. Bringmann, J. Schlauer, H. Rischer, W. Wohlfarth, J. Mühlbacher, A. Buske, A. Porzel, J. Schmidt and G. Adam, Tetrahedron, 2000, 56, 3691 [Links]. | |
| 490 | A. J. Walz and R. J. Sundberg, J. Org. Chem., 2000, 65, 8001 [Links]. | |
| 491 | A. Fontana, P. Cavaliere, S. Wahidulla, C. G. Naik and G. Cimino, Tetrahedron, 2000, 56, 7305 [Links]. | |
| 492 | A. G. Myers and D. W. Kung, Org. Lett., 2000, 2, 3019 [Links]. | |
| 493 | B. Zhou, J. Guo and S. J. Danishevsky, Tetrahedron Lett., 2000, 41, 2043 [Links]. | |
| 494 | C. Cuevas, M. Perez, A. Francesch, C. Fernandez, J. L. Chicharro, P. Gallego, F. De la Calle and I. Manzanares, PCT Int. Appl. WO 00 69862 (Chem. Abstr., 2000, 133, 17616) | |
| 495 | J. L. Chicharro, C. Cuevas, M. Perez, M. J. Martin, M. Flores, A. Francesch, P. Gallego, M. Zarzuelo, F. De la Calle, J. Garcia, C. Polanco, I. Rodriguez and I. Manzanares, Org. Lett., 2000, 2, 2545 [Links]. |
| This journal is © The Royal Society of Chemistry 2002 |